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                                                      INTRODUCION 
India is a country of rich tradition and culture. Siddha system of medicine is a 
traditional medicine originate and practiced in ancient South India. 
The predominant aim and object of Siddha Science is to assure the full span of 
long healthy life to enable ma acquire knowledge, cultivate good character and 
conduct with which they could enjoy their legitimate worldly pleasures & ultimately 
attain salvation. Moreover the diseases can be formed due to changes in the mind also. 
Mind is influenced by various stresses in our day to day life . But Siddhars quoted vey 
anciently that many of the diseases were caused by Psychosomatic problems. So that 
they had advised to control one‟s mind to get rid of stress. This was quoted by 
Agasthiyar as follows ,  
“kdkJ nrk;ikahdhy; ke;jpuk; nrgpf;f Ntz;lh 
kdkJ nrk;ikahdhy; thAit cah;j; Ntz;lh 
kdkJ nrk;ikahdhy; thrpia epUj;j Ntz;lh 
kdkJ nrk;ikahdhy; ke;jpuQ; nrk;ikahNk” 
     - Qhd ghly; 
 
According to Siddhars, human body is constituted by five basic elements 
which also constituted the environment viz Nilam (Earth), Neer (Water), Vayu (Air), 
Theyu (Fire), Agayam (Ether). 
The Siddha system also recognizes the role of three humours called 
Mukkutram   (Vatham, Pitham, Kabam). The normal functioning of human body is 
based on homeostatics of three vital forces or derangement in this homeostatics leads 
to pathologiacal condition called‟ Pini‟ or „Noi‟. 
The factors which maintain constant homeostatics of these three humours are 
by six tastes (Arusuvai), life style, dietary habits and paruvakalam etc. 
Siddhars classified disease into 4448 types. Siddhars diagnosing the diseases by 
means of envagai thervu which includes naadi , nerkuri and neikuri. Neerkuri and 
neikuri are the precious diagnostic tool. 
The treatment aspect involves the neutralization of affected humours. 
By giving viresnam (Purgation), vatha kutram is neutralised. By giving 
vamanam (Emetics) pithakutram is neutralised. Kabakuttram is neutralized by giving 
Anjanam and Nasiyam (application of medicine in the eyes as well as nose). 
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The advantage and unique features of Siddha medicine is the removal of root 
cause of the disease. 
Medicine is defined as one which removes distress and leads an individual to 
perfect happiness(heavenly bliss). 
From the above quoting, it is ideal to choose herbals initially, if no 
improvement then parpam and chendhuram are to be used. 
Siddha physicians based their diagnostic on mukkutram and envagai thervu 
(eight entities) i,e Naadi (Pulse), Sparisam (Touch), Naa (Tounge), Niram (Colour), 
Mozhi (Voice), Vizhi (Eyes), Malam (Feces), Moothiram (Urine). 
There are many diseases commonly affecting the middle aged and elderly 
people one among them is Yogi told „Santhuvatham‟ which is given importance as it 
is mainly interfering with the principle function of human beings ( i,e) locomotion. 
So here the author of this dissertation work has selected „Santhuvatham‟ under 
the vatha diseases explained by munivar vaithiya chindhamani perunool 800 and a 
clinical entity comparable to polyarthritis in modern medicine. 
Hence the author is interested to try effective remedy to this patients as said in 
Siddha literatures with the application of basic principles of Siddha and also 
supporting by Siddha and modern diagnostic parameters. 
The medicine chosen to this disease are  
1.KODIVELI CHOORANAM- INTERNALLY 
Ref: Yugi vaithiya kaviyam 
2.THIRUGUKLLI ENNAI- EXTERNALLY 
Ref: Yugi vaithiya kaviyam 
I have studied clinically santhuvatham on the basis of Siddha concept on 
coarse disease, diagnosis, prognosis, treatment, diet aspects and external therapy in 
my dissertation work. 
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AIM AND OBJECTIVES 
  
AIM 
 Phase II clinical study on  “SANTHU VATHAM” (polyarthritis) and the drug 
of choice is “KODIVELI CHOORANAM” (Internal), “THIRUGUKALLI  ENNAI” 
(External), and OTTRADAM ( External therapy) 
 
OBJECTIVE: 
Primary objective 
 To evaluate the Therapeutic efficacy of KODIVELI CHOORANAM 
(INTERNAL) & THIRUGUKALLI  ENNAI (EXTERNAL) in the treatment of 
SANTHUVATHAM. 
 
Secondary objective: 
1. To evaluate the effect of otradam in the management Of 
SanthuVatham.  
2. To evaluate the Siddha cofactor towards the efficacy of the 
trial drug KODIVEL CHOORANAM AND THIRUGUKALLI 
ENNAI and to evaluate the  pharmacological actions.     
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SIDDHA ASPECTS 
   
INTRODUCTION 
fw;w FUthf;Fq; fhjypj;j thflKk; 
gw;Wf; Nfhnyhd;Nw ghpfhuk; - Kw;w 
mtd; nghWg;gpy;yh nyhd;Wkhtjpy;iy 
nad;Nw ,tDzuf; fPh;j;jp mq;F 
Siddha system of medicine is the oldest system of medicine in India. It is 
Dravidian origin and has it entire literatures in Tamil language. Its origin is lso traced 
to mythological sources belonging to the shaviam.  
According to our Siddha system of medicine ,a human being is composed of 
96 basic principles. Among them the first 30 is considered very vital and the rest are 
the manifestation or extension of the first 30 principles. These thathu are universal to 
all human beings in normal condition. This is not only consists of the physical 
components of the human body but also the mental, intellectual components like 
passions, qualities, knowledge, function of sense organs and motor organs and their 
co-ordination. 
The basic of Siddha system are based on five basic elements of the universe, 
96 thathuvam ,three humours and seven thathus. The three humours of the human 
system are vatham, pitham and kabam. In normal persons these three humours always 
gets deranged owing to a relative increase or decrease of any one or more of the 
principle humours which causes diseases. 
The term „Vatham‟ means „wind‟ but the function of vatham is controlled by 
central nervous system as quoted in the Udal thathuvam. Like that the term „Pitham‟ 
not only mean „Bile‟ but signifies the function of thermogenesis or heat production 
and metabolism, comperhensing in its scope the process if digestion, coloration of 
blood formation of various secretion and excretions which are either the means or the 
end of tissue combustion and all the functions are controlled by Autonomous nervous 
system. The „Kabham‟ not only mean „Phlegm‟ but it is used primarily to imply the 
functions of heat regulations and secondarily formation of the various preservative 
fluids (e.g) mucus, synovium and its functions are maintained by cells. By knowing 
these basic principles we can easily study cause, classification, diagnosis and 
treatment of the disease. 
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DEFINITION OF VATHAM 
Among the five elements ( Panchabothas) vatha is formed by the vayu 
and ahayam. This is one of the three humours (Vatha, Pitha, Kabam). The two 
other dhosas are set in motion by the vatha. In a healthy man the existence of 
three humours are in the ratio of 1:1/2:1/4 respectively. 
      toq;fpa thjk; khj;jpiu nahd;whfpy; 
 joq;fpa gpj;je; jd; dpyiu thrp 
 moq;Fg; fge;jh dlq;fpa fhnyhby; 
 gpwq;fpa rPth;f;Fg; gprnfhd;W kpy;iyNa  
       - Fzthflk; 
This ratio is altered when there is disturbance to the vatha by environmental 
factors, diet, habits, etc., vatha may be increased or decreased, vatha is altered, the 
other two are also altered to vatha disease. 
SYNONYM 
 SANTHU VATHAM = SANTHU + VATHAM, SANTHU – joints, 
VATHAM – Derangement of the vatham constituent therefore, we can say that santhu 
vatham means the joints are affected by derangement of vatham. 
 In siddha system of medicine, a human being is composed of 96 basic 
principles, among them the first thirty is considered very vital and the rest are the 
manifestation on extension of the first 30 principles.  These thathuvas are universal to 
all human beings in normal condition.  This not only consist of the physical 
components of the human body but also the mental, intellectual components like 
passions, qualities, knowledge, functions of the sense and motor organs and also their 
coordination.  
 Pancha boothas are the foundations for three dosham vatham, piththam, kabam 
which are the pillars that support our body structure. 
 Vaayu constitute vatham 
 Theyu constitute piththam 
 Appu constitute kabam 
 Any alterations in the level of mukkuttrams affect the normal functions of the 
body.  This is obvious from the verses. 
“kpfpDk; FiwapDk; Neha;nra;Ak; E}NyhH 
tspKjyh ntz;zpa %d;W” 
         - jpUf;Fws; (kUe;J) 
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The food we eat has six tastes namely sweet, sour, salt, bitter, pungent, 
astringent. 
Each of them is a mixture of two basic elements. 
,dpg;G  - kz; + ePH 
Gspg;G  - kz; + jP 
cg;G  - ePh; + jP 
ifg;G  - tsp + Mfhak; 
Jth;g;G - kz; + Mfhak; 
fhHg;G  - tsp + jP 
Relationship between Vatham and Suvai 
Aggravating tastes 
 “GspJth; tpQ;Rq;fwp ahw;G+hpf; Fk;thjk; 
 xsp Ath;ifg; Ngwpy; gpj;Jr; rPWk; - fpspnkhopNa 
 fhHg;gpdpg;G tpQ;rpw; fgk;tpQ;R Q;rl;bujr;  
Nrug;Gzh; NehaZfhNj” 
- fz;Zrhkpak; 
 According to this poem the sour and astringent tastes  increase the vatha 
humour. 
Neutralising tastes 
 “thj Nkypl;lhy; kJuk; GspAg;G 
 NrjKwr; nra;AQ; rpiwiak; - Xjf;Nfs; 
 fhue; Jth;frg;Gf; fhl;LQ; Ritnay;yhk; 
 rhug; ghpfhuQ; rhw;W” 
- fz;Zrhkpak; 
 According to this poem sweet, salt and sour can neutralise the vitiated vatha 
humour. Fate of three humours 
 
 “mwpe;jpLk; thjklq;F kyj;jpdpy; 
 gphpe;jpLk; gpj;jk; NguhQ;ryj;jpdpy; 
 kwpe;jpLikak; trpf;Fk; tpe;Jtpy;  
ciwe;jpk;%d;Wf; Fwthe;j ykpNj” 
- jpU%yh; 
 From the above quoting, it is clear that the three humours can be discharged 
through the following routes. 
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 Vatha - Feces 
 Pitha - Urine 
 Kaba - Semen(sukkilam) /suronitham  
 Formation of vatham  
 “te;j fiy %d;wpy; thAthk ghdDld; 
 je;j gpuhzd; rkhdDk; re;jKwf; 
 $l;LwT Nurpj;jy; $Wk; thjk;  
gpj;jk;ehl;Lq; fgNkahk; ehL” 
                          - fz;Zrhkpak; 
“,Ug;ghd ehb vOgNjhB uh 
 apukhd Njfj;jpy; Vyg; - ngUehb 
xf;fj rkj;njhopiy A+f;fjr thAf;fs; 
 jf;fgb nad;Nw rhUk; 
rhUe; jrehb jd;dpy; %yk; %d;W 
 NgUkplg; gpq;fiyAk; gpd;dYld; - khWk; 
ciuf;f tpuw; fhw;nwhl;Lzh;j;JNk ehrp 
 tiur; RopNahikaj;jpy; te;J” 
                          - Neha;ehly; Neha;Kjdhly; 
 According to this the human body is composed of 72,000 naadi narambukal.  
Among this 72,000, ten are prominent naadies (Dasa naadies).  Of these ten naadies, 
Idagalai, pingalai and suzhumunai are known as moolaathara naadies. 
 Among the ten vayus five are more important.  These are piranan, abanan, 
viyanan, udhanan and samanan. 
mghdd;  + ,lfiy = thjk; 
gpuhzd;  + gpq;fiy = gpj;jk; 
rkhdd; + ROKid  = fgk; 
  Abanan in conjunction with idagalai to produce vatha. 
  Piranan in conjunction with pingalai to produce pitha and samanan in 
conjunction with suzhumunai to produce kapha. 
 These three humours or thadhus i.e., vatha, pitha and kapha are the functional 
principles in the composition and substance of the body. 
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Location of vatham 
Below the navel 
 “ehnkd;w thjj;Jf; fpUg;gplNk Nfsha; 
ehgpf;Ff; fPnod;W etpyyhFk;”             - A+fpKdp 
Location 
Vatham lives in 
 Abanan Stools 
 Idakalai 
 Undhiyin keezh moolam 
 Kaamakodi 
 Hip bone 
 Skin 
 Nerves 
 Joints 
 Hair follicles and 
 Muscles  
Natural properties of Vatham  
Physiologically 
 Giving briskness 
 Inspiration and expiration 
 Functioning the mind, thoughts and body  
 Regulation of the fourteen physiological reflexes (vegangal) 
 Uniform function of the seven  udal kattugal 
 Protection and strengthening of the five sensory organs. 
RECOGNITION OF VATHAM 
Vatham can be recognized in the body by various ways one among the best in 
form the pulse. 
CLASSIFICATION OF VATHAM 
 Vatha can be classified into ten types.  This has been said in Yugimuni 800 as 
follows. 
“Kiwahk; gpuhzNdh lghdd; tpahdd; 
 %Hf;fkh KjhdndhL rkhd dhfk; 
 jpwik ahq; $HkndhL fpUfud;whd; 
 Njt jj;j ndhL  jdQ; raDkhFk;”            - A+fpitj;jpa rpe;jhkzp 
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1. Pranan 
2. Abanan 
3.  Viyanan 
4.  Udhanan 
5.  Samanan 
6.  Nagan 
7.  Koorman 
8.  Kirugaran 
9.  Devadhaththan 
     10. Dhanajeyan 
Each one is responsible for various actions within the body. 
1. Piranan:- (Heart Centre) 
 It refers to the chest and it regulates the respiratory system and helps the 
digestive system. 
2. Abanan:- (Muladhar Centre) 
 The type of vatha corresponds to the pelvic and it is the seat of kundalini 
energy and controls excretions such as sweating, evacuation of stools, ejaculation of 
sperms, micturition, menstruation and parturition(delivery of child). Abana vayu is 
one of the 14 physiological reflex actions (Vegas) of the body. When its expulsion is 
partially or completely obstructed it leads to diseases like vayu gunmam, kudal 
vatham, vali vatham. 
3. Udhanan:- (Throat center) 
 This corresponds to the pharyngeal plexus in the throat region and controls 
breathing and speech. It is also responsible for the physiological reflex actions like 
vomiting, hiccough, cough etc. 
4. Vyanan:- 
It helps in the circulation of energy through the entire nervous system and 
helps in the movements of various parts of the body. It is responsible for the tactile 
sensation. 
5. Samanan: - (Navel center) 
 This corresponds to the solar plexus etc. By balancing the other vayus, the six 
tastes, water and food any one of the vayus is affected, this samanan is also affected. 
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6. Naagan :- 
  It is responsible for the intelligence of an individual. It helps learning different 
arts, singing of good songs etc. It is responsible for blinking, opening of eyes and 
eyebrow raising. 
7. Koorman :- 
  This is responsible for yawning, closing of mouth, yielding strength and also 
blinking. It helps closing and opening of the eyes and shedding of tears. It is 
responsible for the vision. 
8. Kirukaran :- 
  It is responsible for the salivation in the oral cavity and mucous secretion in 
the nasal cavities. It is responsible for good appetite. It helps in meditation. It 
produces cough and sneeze. 
9. Devadhathatan :- 
  It is responsible for the laziness and also lassitude while waking up. It helps 
movements of the eyeball in various directions. It is responsible for quarrelling, 
arguing etc., and also for much anger. 
10. Dhananjeyan :- 
  It is responsible for the swelling all over the body. It produces sensation of 
roaring like the sea in the ears. It leaves the body by blowing up the cranium on the 
3
rd
 day after death.  
SIGNS AND SYMPTOMS OF VATHA DISEASE:- 
 Pricking pain 
 Dull pain 
 Aching pain 
 Tremors 
 Palpitation 
 Spasm 
 Dryness or dehydration 
 Dislocation of joints 
 Weakness of the body 
 Paralysis 
 Constipation 
 Oliguria 
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 Excessive thirst 
 Astrigent taste predominantly in the mouth 
 Excretions like stools, urine, lacrimiation, sweat, becomes black in colour. 
 
ATTRIBUTES OF VATHAM: 
thjj;jpd; Fzk;;;: 
 twl;rp  -  Dryness 
 Fspu;r;rp -  Coolness 
 mZj;Jtk; -  Subtlety 
 fbdk;  -  Roughness 
 mirj;jy; -  Mobility 
 
INFLUENCE OF VATHAM IN MONTHS: 
“thjtHj; jd fhyNkNjh ntd;dpy; 
kUTfpd;w Mdp fw;fl khjk; 
Mjidg; grpNahL fhHj;jpif jd;dpy; 
MlUNk kw;w khjq;fs; jd;dpy; 
NghfNt rpkpf;fpd;w fhykhFk;”                 -  A+fp rpe;jhkzp 
 
 According to this poem vatha may be influenced in the following months 
normally. They are Aadi, Avani, Purattasi, and Iypassi. 
AGONIST QUALITIES OF VATHAM: - 
Normal qualities of vatha are, 
  Dry 
 Cold 
 Subtle 
 Rough 
 Unstable 
 Light 
ANTAGONST QUALITIES OF VATHAM 
 Unctuous „Hot 
 Solid 
 Soft 
 Stable 
 Heavy 
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SIGNS OF HYPERVATHAM 
 Constipation 
 Abdominal disturbances 
 Fatigue 
 Depression of sense organs 
 Giddiness 
 Incoherent speech 
 Rigors 
 Insomnia 
 Fond of eating hot food stuffs 
 Emaciation with blackish discolouration 
 Loss of vigour. 
SIGNS OF HYPOVATHAM 
 Vague pain all over the body 
 Low-pitched voice. 
 Difficulty to do any work. 
 Reduction of intelligence 
 Syncope 
 Symptoms of hyperkapha. 
 
ALTERNATION OF VATHAM 
The types of alternation of vatham 
1. Thannilai valarchi 
Provoked kuttram in its own location is called thannilai valarchi during 
mudhuvenil kalam (Aani- Aadi). 
2. Vettrunilai valarchi 
Provoked kuttram to other location is called vettrunilail valarchi. During 
kaarkalam (Aavani- Puratasi). 
3. Thannilain valarchi 
Provoked mukkutram neutralizing in its own property is called Thannilai 
valarchi. Duration : Vatham gets neutralized during Koodhir kalam (Iypasi- 
Karthigai). 
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 CHARACTERISTIC FEATURES OF VATHAM: 
 “thjNk fjpj;j NghJ thAt nkOk;Gq; fhz;BH 
thjNk fjpj;j NghJ thAte;jpLQ; rd;dpNjh]k; 
thjNk fjpj;j NghJ ty;yLd;nkype;J nfhy;Yk; 
- mfj;jpaHrpfpr;rhuj;djPgk; 
thjk; kpFk; NghJ rd;dpNjhlk; Nghd;w gy tpahjpfs; te;J NrUk;  
 cly; nkypAk;. 
“thjtPW md;dkpwq;fhJ fLg;Gz;lhk; tz;zKz;lhk; 
NkhJfl;L Nuhfk; RuKz;lhk; kpUkYkh Kwq;fhnjd;Wk; 
XJRhpa thj kdyhF eLf;f Kz;lhk; nghUs;fsha;j; 
jPjdNt euk;gprpj;J re;Jfs; NjhWk; fLf;Fk; jpdKk; jhNd” 
- Njud; thflk; 
 Loss of appetite, pain and discoloration, fever and cough, insomnia, tremors, 
pain in all the joints of the body are the characteristics of vatha diseases. 
PITHAM: 
 Pitham is responsible for all the transformation. Pitham is located in urinay 
bladder, heart, head, umbilicus, abdomen, blood, sweat, skin and eye. Pitham is 
classified into 5 types. They are, 
 Anar Pitham - Responsible for digestion of food. 
 Ranjaga Pitham - Responsible for colour of blood. 
 Sathagam - Located in heart and is responsible for normal activities of the 
body. 
 Alosagam - Responsible for normal vision. 
 Prasagam - Responsible for the complexion of skin. 
KABAM: 
 Kabam stabilizes, maintains and lubricates all movements. Kabam is found in 
samanan, semen, brain, head, tongue, nose, bones, bone marrow, fat, nerves, chest, 
blood, large intestine, eye, stomach and pancreas. Kabam is classified into 5 types, 
they are: 
  Avalambagam :  
  Lung is the center for avalambagam. It controls all other forms of kabam. 
 Kilethagam :  
Stomach is the center for kilethagam. It gives moisture and softness to the 
ingested food and helps for digestion. 
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 Bothagam :  
Tongue is the centre for bothagam and it is responsible for the sense of taste. 
 Dharpagam :  
Head is the center for Dharpagam. It gives cooling effect to eyes. 
 Santhigam : 
It lies in the joints and is responsible for the locomotive action of movable 
bony joints. 
THINAIGAL  
Kurinji 
 Physiological function: Mountain and its surroundings 
 Features in santhu vatham: Kabanoi liver disease are common 
Mullai  
 Physiological function: Forest and its surroundings 
 Features in santhu vatham: Pitha and vatha disease liver disease and common 
Marutham 
Physiological function: Field and its surroundings 
 Features in santhu vatham: Safest place to maintain good health 
Neithal 
 Physiological function: Sea and its surroundings  
 Features in santhu vatham: Vatha disease and liver enlargement are common 
paalai 
 Physiological function: Desert and its surroundings 
 Features in santhu vatham: Vatha pitha and kabha disease and common 
Most of the patients came from Marutha nilam.  Patients were also reported 
from neithal nilam. 
UDAL VANMAI 
 It means strength and vitality of the body and classified into three types. 
  Eyarkai vanmai- Inherited immunity 
Kala vanmai – Age, season and time 
Cheyarkai vanmai – improvement of 3 vitality obtained by diet, day to day 
habits and physical exercises. 
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SANTHU VATHAM 
 Santhu vatham is one of the vaatha diseases which is described in “Yugi 
vaithya chinthamani”. 
Definition 
 The term santhuvatham denotes all kinds of joint disease caused by the 
derangement of one of the uyirthathus “Vatham”. 
 In the same literature it is mentioned such type of joint disease as megasoolai 
under the chapter of “Soolai noikal”. In some other literatures, joint disorders are 
mentioned in different names. 
Santhuvali, muttuvali, megasoolai, mudakkuvayu, ama vatham, keelvayu- 
Siddha maruthuvam. 
Sangeegasileshmarogam, Santhu vatham, soolaikattu, vatha soolai, 
vayurogam- vaidya sara sangiraham. 
In vaidya sarasangiraham, alias Agasthiyar Vaidhiya Kaviyam, Agasthiyar 
Gunavahada Thirattu and Thirumoolar Karukkidai Vaidhiyam 600, joint disorders 
were explained in the name of Soolai, because of excruciating pain caused by such 
diseases. Since it causes pain in the Santhu or muttu, it is called asmuttuvali or 
santhuvali. Restriction of movements and in some cases even immobility of the joints 
can occur, so it may be named as Mudakku vayu or Mudakku vatham. Thus the terms 
of this  diseases are named according to the causes of derangement of the Uyirthathu, 
Kurikunam, site of lesion,complication etc. 
They are as follows; 
Causes    mega soolai 
 Derangement of the vatha - Uyirthathu vatha soolai, santhu vatham 
 Derangement of the Kapha - Uyirthathu santheega sileshma rogam 
 Kurikunam   - Soolai kattu 
 Site of lesion    - Muttuvali, santhuvali, keelvayu 
 Complication    - Mudakku vatham 
       
nghJthf mow;rpapdhy; clk;gpy; Koq;fhy; Kjypa nghUj;Jfisj; jhf;fp 
tPf;fq;fz;L typAld; fPy;fisr; Rw;wpAs;s rt;Tfspy; fhZk; Xh;thj Neha; ,J 
KOghfk; my;yJ Xh;ghfk; khj;jpuk; typ nfhs;syhk;. ,J rhj;jpaKk; my;yJ 
mrhj;jpaKkhf ,Uf;fyhk;.  
      -b.tp.rhk;grpt gps;is. 
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A term generally employed to inflammation of the joints, swelling with pain 
affects the whole or greater part of the fibrous structures which surrounds the joint, it 
may be partial or complete and it could be cured or not cured. 
     
   'nra;ifjhd; re;JfS kpfj; jpkph;e;J 
nrlnkq;F nehe;JNk kpftow;wp 
ieifaha; eSj;JNk kaph;$r;rpl;L 
ehzpNa Kd;Nghy eil nfhlhJ 
ikifjhd; kaf;fnkhL tha;ePUWk; 
tuz;bLNk ehTjhd;bf; fbf;F 
ifjhd; juzpjdw;whpf; nfhzhJ 
rQ;rypf; FQ;re;Jthk; thjq;NfNs 
       - A+fpitj;jpa rpe;jhkzp 
 
SYNONYMS: 
Santhuvali (re;Jtsp) 
Moottuvali  (%l;Ltyp) 
Megasoolai (Nkf#iy) 
Mudakkuvaayu (Klf;F thA) 
Aama vatham (Mkthjk;) 
Keelvayu  (fPy;thA) 
- Siddha maruthuvam 
Santheega sleshmarogam (re;jpfrpNy\;k Nuhfk;)  
Santhu vatham (re;J thjk;) 
Soolaikattu (#iy fl;L) 
 Vathasoolai (thj#iy) 
Vayu rogam (thA Nuhfk;) 
- Vaidya sara sangiraham 
In vaidya sarasangiraham 
Agasthiyar vaidhya kaviyam 
Agasthiyar Gunavahada thirattu 
Thirumoolar karukkidai vaidhyam 600, 
Santhu vatham was explained in the name of soolai, because of excruciating pain 
caused by such diseases. 
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Since it causes pain in the santhu or moottu, it is called as moottuvali  or 
sandhuvali. 
Restriction of movements and in some cases even immobility of the joints can 
occur, so it may be named as mudakku vaayu or mudakku vaatham. 
  Thus the terms of this disease are named according to the cause, derangement 
of the uyirthathu, kurigunam, site of lesion, complication etc. 
In TV Sambasivampillai medical dictionary Santhuvatham is described as 
 “re;Jthjk; - nghJthf mow;rpapdhy;  
 clk;gpy; Koq;fhy; Kjypa nghUj;Jfis 
jhf;fp tPf;fk; fz;L> typAld; fPy;fis 
 Rw;wpAs;s rt;Tf;F fhZk; XH thj Neha;”. 
A form generally employed to inflammatory disease acute or chronic of the 
whole or greater part of the fibrous structures that constitute the formation of a joint-
arthritis. 
According to Agasthiyar Rathina surukkam 
 The character of vatha vitiations are joint pain, fever, nausea, body aches, 
constipation and  excessive sweating. 
According to Theraiyar vagadam 
Indicates vatha vitiation causes cough, loss of sleep, swelling of 
interphalangeal, tarsal, metatarsal joints and bony prominence, stiffness of the body 
and excessive salivation. In santhuvatham disease mostly affected types of pitham are 
sadhakam, ranjakam and prasaga pitham. 
According to Yugi vaidya chinthamani 
 “re;Jfs; kpf jpkpHj;J clk;nky;yhk; 
kpf nehe;J kaf;fk; tha; ePUwy;>iffhy; 
G+kpapy; jhpf;fnthz;zhJ typia cz;lhf;Fk; 
thjNeha;”. 
 “Rheumatism is characterised by inflammation with the thickening of the 
fibrous tissues, body pain, giddiness, salivation and unbearable pain in the limbs 
rendering the patient unable to stand firmly”. 
According to Siddha maruthuvam (text book) 
 nra;ifjhd; re;JfS kpfj;jpkph;e;J 
nrlnkq;F nehe;JNk kpftow;wp 
ieifaha; eSj;JNk kaph;f;$r;rpl;L 
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ehzpNa Kd;Nghy eilnfhlhJ 
ikifjhd; kaf;fnkhL tha;ePWk; 
tuz;bLNk ehTjhd bf;fbf;F 
iffhy;jhd; wuzpjdpw; whpf;nfhzhJ 
rQ;rypf; FQ;re;Jthk; thjq;NfNs”. 
  Santhuvatham is a disease characterised by difficulty in walking and inability 
to do the works with hands and legs as usual due to stiffness of joints and pain of the 
body.  Extra articular symptoms associated with this disease are excessive salivation, 
dryness of tongue, lassitude and lethargy. 
  It is a disorder of joints (santhu) where bone, muscles, tendons, ligaments and 
associated structures binds together, for the purpose of locomotion of the body, 
caused by deranged humour vaatha. 
Many literature references reveals above mentioned conditions associated with 
pathological conditions of vatha derangement.  
“thjNk thAthFk; thjNk fhypw;NrUk; 
thjNk fd;dpnahL kUtpby; typTKz;lhk;” 
- guuhr Nrfuk; 
thjNk fjpj;jNghJ thAt nkOg;G kPUk; 
nrhy;yNt thjkJ kPwpw;whdhy; 
NrhHtile;J thAtpdhy; Njfnkq;Fk; 
nky;yNt iffhy;fs rjpAz;lhk; 
nka;Klq;Fk; epkpunthz;zhj; jpkpUz;lhFk;   
nky;yNt Aly; nghUKd; tapWisf;Fk; 
tpUk;gpa d;dQ; nry;yhJ tpe;Jel;lk; 
nfhy;yNt ehg;Gf;Fk; fha;r;rYz;lhk; 
$wpdhH khiyaKdp $wpdhNu”       - mfj;jpah; rpfpr;rh uj;jpd jPgk; 
  Manifestations of vaatha vitiations are pain in extremities and joints, 
abdominal distension, swelling, immobilization of joints and stiffness, perverted taste, 
anorexia, fever etc., 
When vathakapha gets deranged, 
 “tspikAe; jd;dpiy nfl;L 
 typAld; tPf;fr; RuKk; fha;e;J 
 %l;Lfs; NjhWk; KLf;fpNa nehe;J 
 %l;Lfs; jd;dpy; ePUk; Rue;J 
 jhq;nfhzh typAld; nehe;jpLkk;Nk” 
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Its manifestation are pain, swelling and fever associated with unbearable pain 
of the joints and increased secretion of synovial fluid. 
Clinical features of santhuvatham 
 “thjgpj;jf; fPy;thAtpd; tUq;Fwp rhw;wf; Nfsha; 
 VjkhH ke;j Nkg;gk; ,iur;rYk; tapw;wpy; ehZk; 
 XjUq; Fj;jy; tPf;fk; Xa;jypd; vhpr;rYz;lhk; 
 fhjWKwf;f kpd;ik fha;rYq; fhZq; fz;lha;”. 
- rghgjp ifNaL 
 Indigestion (Mantham) Eructation  - Yeppam 
 Borborymus of the abdomen 
 Pricking pain 
 Burning sensation 
 Swelling of the affected joints, fever, insomnia and laziness. 
Complications of Santhuvatham 
 As the disease progresses, joint diseases leads to deformity and 
immobilization of the limbs.  In Siddha system such conditions are named as 
mudakku vatham, 
 “gj;jpa thje;Jaj;J ghFNk gapj;jpaj;jhy; 
 vj;jpa euk;gpKj;J NkyJQ; RUz;L nfhs;Sk; 
 Fj;jpNa Jisj;jhw; Nghy; File;J fhyile;J fhZ 
 kw;wpJ Klf;F thjkh nkdf; fUjyhNk”. 
- A+fpKdpth; ngUE}y; itj;jpafhtpak; -1000 
 It denotes, in mudakku vadha condition body will bend forward and rounding 
the shoulder probably due to vertebral column deformity (Hang dog position).  
Envagai Thervugal includes 
 Naadi, sparisam, naa, niram, mozhi, vizhi, malam, moothiram. 
Naadi (pulse) 
 “mwpe;J ghH thjNk jdpj;j jhdhy; 
 md;dk; Nghy; elf;Fkg;gh ehb ghU 
 rhpe;jplNt fhy; Klf;Fk;NghJ fhl;Lk;” 
- mfj;jpah; uj;jpd RUf;fk; 
 Vitiated vatha causes difficulty in walking or impaired function of lower 
extremities. The examination of naadi has been recognised as one of the principle 
means of diagnosis and prognosis of disease from times immemorial. 
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Sparisam (skin) 
 Skin examination can be made out by touch and reveals about warmness, 
chillness, dry, weeping, skin rough, smooth, soft, hard, tenderness or presence of 
ulcers, swelling, wrinkles, hair, pigmentation etc., Naa (Tongue) 
 The colour, character and condition of the tongue changes according to the 
changes in mukkutrum. 
Niram (colour): 
 As vaatha is the root cause the colour of the patient‟s skin, tooth etc., should 
be dark or black in colour. 
Mozhi (Speech): 
 Speech in vatha patients may vary according to the deranged dhosas and grade 
of the disease. 
Vizhi (Eye): 
 Burning of the eyes, lacrimation, irritation, colour changes are also noticed 
under this group.  In Santhuvatham patients no changes in the eyes. 
Malam (stools): 
 In Santhuvatham patients stools should look in dark colour with constipation. 
Moothiram (urine) : 
 “ciwe;j ePUq; fU fUj;J 
 Kiwaha; NuhfK Kz;lhNk”         
 “muntd ePz;bbd/Nj thjk;”    -mfj;jpah; ehb 
When the oil drop spreads like a snake it indicates vathaneer. 
PROGNOSIS 
A full of knowledge about prognosis will save the patient as well as the 
physician from considerable difficulties. The knowledge of prognosis is most 
important for a physician to have a perfect and proper line of treatment and 
prevention. In santhuvatham the course of the disease is depend on the pirakiruthi 
disturbed vatha, pitha, kabha and kalavanmai, cheyarkai vanmai and stages of the 
disease. Prognosis depends on the affected thridosha. Commonly it is difficult to yield 
permanent care, later stage of the disease produce ankylosis. Gradually all movements 
joints becomes restricted. 
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UYIR THATHUKAL 
Vatham                              
Table 3.1 
S.NO Vatham Pysiological function 
Features in 
Santhuvatham 
1. Pranan Inspiration and expiration 
responsible for sneezing 
coughing and belching. 
Not affected 
2. Abanan Act with downward 
movement. 
Affected( constipation) 
3. Viyanan Helps in various 
movements of body, 
responsible for sensation. 
Affected ( restricted 
movement of affected 
joints radiating pain also 
present with tingling. 
4. Udhanan Regulates the higher 
functions of brain. 
Responsible for 
physiological reactions like 
hiccough and vomiting. 
Not affected 
5. Samanan Regulates all other vayus Affected 
6. Nagan Responsible for 
intelligence helps in 
opening and closing of 
eyes. 
 Affected in aged 
patients. Acuity of 
vision is diminished. 
7. Koorman Responsible for 
lacrimation. Helps in 
visualization of all things 
of world 
Not affected 
8. Kirukaran Salivation, mental agony Not Affected 
9. Thevathathan Responsible for laziness. 
Rotation of eyeballs. 
Affected in 
sleeplessness patients. 
10. Thanajeyan Responsible for tinnitus 
oedema. 
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Pitham 
Table 3.2 
S.NO Pitham Physiological functions 
Features in 
santhuvatham 
1. Anapitham Digests all the ingested 
particles. 
affected 
2. Ranjaga ptham Increases the blood and 
gives colour to the blood 
Affected 
3. Santhiga pitham Makes the works to 
complete what mind thinks 
to do. 
Affected             
(restricted) 
movements and 
pain present. 
4. Prasaga pitham Gives colours to skin. Not affected 
5. Alosaga pitham Responsible for clear vision. Affected in old 
age peoples. 
 
Kabam 
Table 3.3 
S.NO Kabam Physiological function 
Features in 
santhuvatham 
1. Avalambagam Controls other 4 types of 
kabam 
Affected 
2. Klethagam Moistens the food Not affected 
3. Bothagam Helps to know the taste Not affected 
4. Tharpagam Gives cooling effect to the 
eyes 
Not affected 
5. Santhigam Gives lubrication to joints Affected ( pain 
and restricted 
movements 
present) 
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SEVEN PHYSICAL CONSTITUENTS OF BODY 
Table 3.4 
S.NO Kabam Physiological function 
Features in 
santhuvatham 
1. Saram Strengthens the body and 
mind 
Affected 
2. Seneer Preserves brightness, 
boldness, power& 
knowledge 
Affected 
3. Oon Gives structure and shape to 
the body 
Early stage- not 
affected 
Later stage – 
Affected 
4. Kozhuppu Responsible for movement 
lubricants the joint 
Affected 
5. Enbu Responsible for joint 
movements 
Affected 
6. Moolai Present inside the bones and 
gives strength to the bones 
Affected 
7. Sukkilam or 
Suronitham 
Responsible for next 
generation of human 
beings. 
Not affected. 
 
 
Thinai (land and place) 
 The geographical distribution of the land is classified into five regions. 
1. Kurinji  - Mountain and its surroundings 
2. Mullai  - Forest and its surroundings 
3. Marutham - Field and its surroundings 
4. Neithal - Sea and its surroundings 
5. Paalai  - Desert and its surroundings 
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 Accordingly, vaatha diseases are common in  neithal nilam.  Palai nilam-
common places for all  types of diseases.  Marutha nilam is good for all types of 
treatment and health 
Kalam 
 According to siddha system the year is divided into six seasons with reference 
to the position  of earth and sun. 
S.No. Paruvakalangal Kuttram 
1. Kaarkalam   –  August, September   Vatham ↑ ↑Pitham  ↑ 
(Mtzp> Gul;lhrp)  
2. Koothirkalam  - October, November  Vatham (-)Pitham  ↑ ↑ 
(Ig;grp> fhHj;jpif)  
3. Munpanikalam- December, January  Pitham  ↑ 
(khHfop> ij)  
4. Pinpanikalam -  February, March  Kabam  ↑ 
(khrp> gq;Fdp)  
5. Ilavenilkalam - April, May    Kabam ↑ 
      (rpj;jpiu> itfhrp)  
6. Muduvenilkalam - June, July)    Vatham  ↑  
(Mdp> Mb)    Kabam (-) 
Kabam (-)Kaarkalam 
“ntspr; Roy; jl;gj;ij tpQ;Kl; #l;il 
mspj;Jhpf;F Neh;nrAkhy; ahf;iff; - fsp nrhp 
td;dpa/Fk; fhzj;jhy; thjhjp Kj;Njhlk; 
ed;dpiyapy; epy;yh etpy;” 
                 - kUj;Jt jdpg;ghly; 
These above mentioned poem stated that the kaar and muthuvenil kalam are 
seasons for vatha diseases 
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SANTHUVATHAM AFFECTED IN 96 THATHUVAM 
Table 3.5 
S.NO Thathuvam 
Affected 
thathuvam 
Symptoms 
1. Bootham Mun, Appu, 
Vayu and 
Aagayam 
Deranged vatham4 boothams 
2. Pori Mei Aagaya bootham develops Mei 
3. Pulam Ooru Pain and tendness 
4. Kanmenthiriyam Kaal and Kai Pain, numbness, weakness, 
destroying, loosening,burning 
5. Kanmavidayam Kamanam, 
Thamanam 
Difficulty to normal 
movements in limbs 
6. Naadi Edakalai, 
Pingalai, 
Suzumunai 
Three humours are found by 
these naadies. 
7. Vayu Piranan Deranged vatham 
Samanan Vayu increased in jonts. 
Devathathan Drowsiness, tremor 
Abanan Constipation  
Udanan Salivation, dryness of mouth 
Kirugaran Salaivation, mental agony. 
8. Kosam Vali udambu Deranged three humours and 
seven udal thathu, drowsiness, 
mental agony, weakness. 
9. Aatharam Moolaratham Weakness 
Swathitanam Drowsiness 
  Manipooragam Destroying 
Anagatham Burning sensation 
Visuthi Tremor 
Aakinai Dryness of mouth 
10. Gunam Thamo kunam Drowsiness 
Mental agony 
Thamogunam is one of the 
main etiology. 
11. Vinai Thee vinai Thivinai is one of the main 
etiology for the santhuvatham. 
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AFFECTED UYIR THATHUKAL 
Table 3.6 
1. Vatham Piranan Deranged vatham 
Abanan Constipation 
Viyanan Pain and numbness in 
joints 
Samanan Pain all over joints 
Kirugaran Salivation, mental agony 
Devathatham Drowsiness, ,mental 
agony 
2. Pitham Sathagam Difficulty to work due to 
pain and numbness, 
mental agony, tremor 
weakness 
3. Kapham Santhigam Destroying, loosening, 
inflammation, burning 
sensation in joints, 
chillness of 
joints,weakness, 
pinching of joints. 
 
AFFECTED UDAL THATHIKAL 
Table 3.7 
Affected udal thathukal Symptoms 
Saaram Salivation, dryness of mouth 
Oon Wasting, destroying, weakness 
Kozhuppu Destroying, chillness, inflammation, 
difficulty in movement of joints 
Enbu Burning sensation of joints, loosening, 
pain in allover the joints. 
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Neha; epjhdk; (DIFFERENTIAL DIAGNOSIS): 
fhshQ;rfthjk; (Kalanjaga Vatham): 
 Though the patient had numbness in both upper and lower limbs, twisting pain 
in joints destroying and inflammation, difficulty to walk, emaciation, cripple, rigidity 
due to morbid enlargement, wasting in body, pallorness, itching, ulcer, deranged 
iyyam, indigestion, drowsiness, it is not santhuvatham. 
thjRNuhzpjk; (Vatha suronitham) 
 Though the patient had Wasting in whole body, swelling in joints, difficulty to 
walking, swelling in carpal joints, itching in all over the body, loss of appetite, coma, 
salivation, it is not sathuvatham. 
cjputhjRNuhzpjk; (Uthiravatha Suronitham) 
 Though the patient had, swelling in ankle joint, knee joint and heel pain and 
inflammation in carpal and tarsal joints, drowsiness, exhausted, madness, deranged 
Azhal humour, loss of appetite, it is not santhuvatham. 
NkfR+iy (Mega Soolai)  
Though the patient had pain in lower back and both limbs, constipation 
absolute suppression of urine, sweating in both limbs, shivering, redness in lips, 
wasting, burning sensation all over the body, fever, thirst, perplexity, mental delusion, 
it is not santhuvatham. 
thjR+iy (VathaSoolai) 
 Though the patient had, pain in both limbs, numbness, coma, pain in the body, 
chillness, pallorness in body and face,pain in the thigh, burning micturation, 
haematuria, pain increase in the body, it is not santhuvatham. 
gpj;j#iy (Pitha soolai) 
 Though the patient had wasting and emaciation, pain in both limbs and joints, 
deranged humours, pallorness in all over the body, drowsiness and delusion, it is not 
santhuvatham 
 Santhuvadham is differentiated from other types of keel vaayu as follows: 
tspmoy; fPy;thA (Vali Azhal Keel Vaayu) 
 It is characterized by excruciating pain and swelling involved in toes, knee 
joints, hip joints, elbow joints, shoulder joints and associated with systemic 
disturbances like dryness of mouth, pyrexia, headache, palpitation, constipationand 
sweating. In advanced cases it may affect the heart and produce “Thamaraga Vaayu”. 
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IafPy;thA (Iyakeel vaayu) 
 It is characterized by severe pain in the joints associated with emaciation of 
the body, anorexia, insomnia, cough, hiccough, vomiting, anemia and dropsy. The 
common sites are spinal cord, hip joint and knee joint VALI IYAKEEL VAAYU: 
 It is characterized by pain in the joints associated with effusions of joint fluid 
and swelling, restricted joint movements, pyrexia, fainting, insomnia, especially in 
knee joint asymmetrically, lymphadenopathy, generalized malaise, atrophy of the 
affected limb etc., The affected joint looks like “Fox‟s head”. 
LINE OF TREATMENT 
 According to siddha system, the main aim of the treatment is to cure physical 
illness and mental illness.Treatment is not only for complete healing but also for the 
rejuvenation .Siddha system of medicine has a sophisticated treatment modality.  It 
not only cures the disease but it corrects the causative factors and insists to advise 
certain life style modification in order to prevent the disease again. 
 Thiruvalluvar says about physicians duty, study the disease, study the cause, 
seek subsiding ways and do what is proper and effective. 
„Neha;ehb Neha;Kjdhb aJjzpf;Fk; 
tha;ehb tha;g;gr; nray;” 
„cw;whdsTk ;gpzpasTq; fhyKk; 
fw;whd; fUjpr; nray;”;     - jpUf;Fws; 
 So it is essential to know the disease, the aetiology, the nature of the patient, 
severity of the illness, the seasons and the time of occurrence must be observed 
clearly. 
Line of treatment is as follows: 
In Siddha system line of treatment consists of the following 
1.Neekam (Treatment) 
2. Niraivu (Restoration of wellbeing) 
3. Kappu (Prevention) 
NEEKAM: 
a) To bring the Three Thodams to equilibrium state. 
b) To treat the patient by Internal and external medicines. 
c) To stabilize seven Udal thadhukal and three Uyir thadhukal. 
 To bring the three Thodams to normal equilibrium state-by giving purgation.  
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Purgation drug: 
 Purgation was given in early morning for balancing the deranged mukkutram 
on the first day of the treatment. Next day onwards the trial drugs 
.SANTHUVATHACHOORANAM (internally) and VATHA ENNAI (externally) 
were given. 
NIRAIVU: 
 By promoting the awareness about the dietary, seasonal, emotional influence 
on the disease assurance from disease recovery was given. Life-style modification 
was also advised to them. 
KAAPU: 
 It means prevention of human beings from disease. As per siddha system the 
vinaipayan (kanmam) is transferred to the fertilized embryos at the time of 
conception. This vinaipayan produces certain incurable chronic diseases. Moreover 
one should try to neutralize the vinai payan before his lifetime because, his negative 
effects are transferred to his hereditary.  
One should simply eliminate the vinai payan through some simple life style 
modification or regulations. Further the physician must advise all the patient to follow 
the following habits. 
 Living with good moral habits 
 Avoid excessive sex with many persons 
 Avoid stress, fear and anxiety 
 Always follow good dietary pattern 
 Avoid exposing chill weather and rain 
 Take oil bath regularly 
 Avoid intake of alcohols 
 Avoid kabha producing foods 
 Always do some simple yogas and medication 
 Always have good positive thoughts 
DIETARY ADVICE: 
 In Siddha system of medicine the importance of dietary habits have been 
emphasized for the management of diseases and its prevention in a effective manner. 
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“fLF ew;wpyj; njz;nza; $o;ghz;lq;fs; 
t^t jhNa njz;nza; $o;ghz;lq;fs; fliy 
kbtp yhjnts;Ss;spnfhs; Gifapiy kJngd;  
,lW ghfNyh lfj;jp ePf;fplypr; rhgj;jpak;” 
- rpj;j kUj;Jthq;f RUf;fk; 
During the course of treatment, the patients were advised to follow certain diet 
regimen (Icha pathiyam) which is mentioned for vatha diseases. 
1. Kadugu - Brassica nigra (Mustard seed) 
2. Ell Nei - Gingelly oil 
3. Poosanikkai - Bennicasa hispida 
4. Kadalai - Arachis hypogea 
5. Thengai - Coccus nucifera 
6. Maangai - Mangifera indica 
7. Poondu - Allium sativum 
8. Pala - Artocarpus heterophyllus 
9. Kollu - Horse gram 
10. Pugaiyilai - Nicotiana tobaccum 
11. Pagal-- Momordica charantia 
12. Agathi - Sesbania grandiflora 
13. Sour taste 
14. Astringent taste 
 Substances used for neutralizing three humours are: 
“xd;wpa thjgpj;j fgkpit Aauh tz;zk; 
ed;wW fwp fnsy;yhk; ehSNk rikg;guha;NjhH 
jpd;wpL kpsF kQ;rs; rPuf KaHe;j fhak; 
ntd;wp nfhs; Rf;NfhNlyk; nte;jpak; cs;sp NrHNj” 
- g.F.rp 
To maintain three vital humours in equilibrium one should take food cooked 
with: 
Pepper  -  Piper nigram 
Turmeric  -  Curcuma longa 
Cumin seeds  -  Cuminum cyminum 
Asafoetida  -  Ferula asafoetida 
Dry ginger  -  Zingiber officinalel  
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Cardamom -  Elettaria cardamomum 
Fenugreek  -  Trigonella foneum 
Garlic   -  Allium sativum 
Substances advised for vatha diseases are : 
“nrq;fOePH Nfhilj; Njd; kpsF ey;nyz;iz 
jq;F ngUq;fhaj; jOjhio - vq;nfq;Fk; 
fl;L rpW Kj;J nea; Nfhjpy; cSe;Jitfs; 
thl;L kzpyf;if kjp” 
- g.F.rp 
 Honey collected during summer 
 Pepper  -  Piper nigram 
 Gingelly oil  -  Sesamum indicum 
 Asafoetida  -  Ferula asafoetida 
 Castor oil  -  Riccinus communis 
 Black gram  -  Vigna mungo 
 Garlic   -  Allium sativum 
NrHf;ff; $ba czTfs;: (Diet to be included) 
fha;fs; (Vegetables): 
 fj;jhpg;gpQ;R  - Unripe brinjal 
 KUq;ifg; gpQ;R  -  Unripe drumstick 
 mtiug;gpQ;R  - Unripe broadbeans 
fPiufs; (Greens): 
 nghd;dhq;fz;zp       - Alternanthera sessilis 
 %f;fpul;il  - Boerhaavia diffusa 
 JhJNtis  - Solanum trilobatum 
 KUq;iff;fPiu - Moringa oleifera 
 fwpNtg;gpiy  - Murraya koenigii 
 Klf;fWj;jhd; -     Cardiospermum halicacabum 
 mWfPiu  -       Amaranthus tristis 
fhprhiy  -           Eclipta prostrate 
goq;fs; (Fruits): 
 khJis  -      Pomegranate 
 Mg;gps;  - Apple 
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 gg;ghsp  - Papaya 
 MuQ;R   - Orange 
 NghPr;ir  - Dates 
 mj;jp   - Figs 
 ehty;   - Syzygium cumini 
mirtk; (Non-Vegetarian diet): 
 nts;shl;Lf;fwp -      Meat 
 fhil   -      Quail 
 rpW ,why; kPd; -       Prawn 
                                                 
FOEMENTATION 
Definition 
A fomentation consists of a local application of moist heat to the body surface.  
A fomentation is usually made of blanket material.  50% wool to retain heat and 50% 
cotton to retain moisture and be more durable. 
Physiologic effect 
1. Promotes increase in circulating white blood cells. 
2. Increases blood flow to the skin, thereby relieving internal congestion. 
3. Relieves muscle spasm by increasing circulation and releasing muscle tension. 
4. Relieves pain in muscles and joints by counter-irritation and de congestion. 
5. Reflexly relieves pain from internal organs. 
6. Increases elimination by promoting sweating 
7. Stimulates or sedates according to the temperature of the application. 
Indications 
1. Joint pain 
2. Neuralgia and Neuritis pain 
3. Muscle tension 
4. Insomnia 
5. To warm the tissues in preparation for massage. 
6. To prepare for cold procedures. 
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Contra indications and cautions 
1. Loss of skin sensation due to unconsciousness paralysis of the part legs and 
feet of diabetic 
2. Leg or feet oedema, varicose veins, advanced vascular disease. 
3. Malignancy 
4. Tendency to bleed (haemorrhage) 
5. Stomach or bowel ulcers. 
6. Omit cold in extreme pain such as pleurisy, Renal colic and dysmenorrhoea. 
xw;wlk; (Fomentation) 
 kUe;J nghUl;fis tWj;J Jzpapy; Kbe;J NehAs;s ,lq;fspy; 
xw;Wjy;. 
 It is also one of the 32 external theraphies of siddha medicine by application of 
hot medicated packs. 
 The medicated pouches are made up of leaves that contains. 
 Pelonex elata (thj ehuhazd; ,iy) 
 Tamarindus indicus (Gspapiy) 
 Vitex negundo (nehr;rp) 
 Cleodendrum phlomoidis (jOjhio) 
Uses 
 Increases blood circulation and reduces pain. 
34 
 
MODERN ASPECT 
JOINT  
A joint or articulation is the connection made between bones in the body 
which link the skeletal system. 
CLASSIFICATION OF JOINTS 
1. Clinical, numerical classification 
Monoarticular – Concerning one joint 
Oligorticular or pauciarticular – concerning two to four joints 
Polyarthritis – concerning five or more joints 
2. Structural classification: 
Fibrous joint – joined by dense regular connective tissue that is rich in 
collagen fibers 
Cartilaginous joint – joint by cartilage 
Synovial joint – not directly joined- the bones have synovial cavity and are 
united by the dense irregular connective tissue that forms the articular capsule that is 
normally associated with accessory ligaments. 
Facet joint – joint between two articular processes between two vertebrae. 
3.Functional classification: 
Synarthrosis – permits little or no mobility. Most synarthrosis joints are 
fibrous joints. They are classified according to the type of tissue found between the 
articulating bones. 
Sutures – found between the membrane bones. 
Synchondrosis – found between cartilaginous bones 
Synostosis: 
Structure or synchondrosisossify,the joint disappears. 
Amphiarthrosis – permits slight mobility. Most amphiarthrosis joints are cartilaginous 
joints ( e.g.invertebral discs). 
Synovial joint ( also known as diarthrosis) – freely movable. Synovial joint 
can in turn be classified into six groups according to the type of movement they allow. 
They are: 
 Plane joint 
 Ball and socket joint 
 Hinge joint 
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 Pivot joint 
 Saddle joint 
 Condyloid joint 
4.Axial classification: 
 Uniaxial 
 Biaxial 
 Multiaxial 
5.Biomechanical classification: 
  Simple joint- two articulation surfaces( e.g. shoulder joint, hip joint) 
 Compound joint – three or more articulation surfaces (e.g. radiocarpel joint) 
 Complex joint – two or more articulation surfaces and an articular disc or 
meniscus ( e.g. knee joint) 
6.Anotomical Classification: 
 Joints of hand 
 Elbow joints 
 Wrist joint 
 Axillary articulations 
 Sternoclavicular joints 
 Vertebral articulations 
 Temporomandibular joints 
 Sacroiliac joints 
 Hip joints 
 Knee joints 
 Articulations of foot 
CARTILAGINOUS JOINT 
Cartilaginous joints are connected entirely by cartilage (fibrocartilage or 
hyline). They are classified into the following types: 
 Primary cartilaginous joint 
 Secondary cartilaginous joint 
BURSAE 
This is a sac of synovial membrane surrounded by fibrous tissue. They 
facilitate movements. They may be continuous with the joint cavity. (e.g.) supra 
patellar bursa of knee joint. 
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ARTICULAR DISC 
In some joints there may be fibro cartilaginous pads. They divide the joint 
cavity into two components.Eg: 
 Sternoclavicular joint 
 Temporo mandibular joint 
 Knee joint 
SYNOVIAL MEMBRANE 
Synovial membrane lines non- articular areas in synovial joints, bursae and 
tendon sheaths, all regions where movement occurs between opposed surfaces, which 
are lubricated by a fluid superficially like egg albumin (synovia) secreted and 
absorbed by the membrane. It lines fibrous capsules and covers exposed osseous 
surfaces, intra capsular ligaments and tendons. 
SYNOVIAL FLUID 
Synovial fluid is a clear, viscous, pale, yellow, fluid, with a specific gravity of 
1.008 to 1.015, which fills the synovial  cavity. It is a dialysate of the blood plasma 
with mucin and hyaluronic acid added t it as secretions from the synovial cells. 
Analysis of the synovial fluid is helpful in diagnosing various types of arthritis 
by changes in its viscosity, cell content and biochemical features. Approximate 
amount and ranges ofsubstances in synovialfluid. 
FUNCTIONS: 
1. The main function of synovial fluid are lubrication and nourishment of the 
articular cartilage. 
2. Synovial fluid includes provision of a liquid environment, small in range of 
pH, for joint surface nutrition of articular cartilage, disc and menisci 
lubrication and reduction  of erosion. 
3. Synovial membrane not only produces fluid but also removes materials from 
the articular cavities. 
THE SYNOVIAL CAVITIES 
The joint cavities and the bursae are known as synovial cavities. The synovial 
membrane at all, but only a collection of dense fibrous tissue cells that lines the 
surface between the interstitial spaces and cavities. For this reason these cavities 
might be considered to be nothing more than enlarged tissue spaces. However the 
synovial cavities do contain amounts of mucopolysaccharides much than normally 
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present in the interstitial fluid. The origin is not known through presumably it is 
secreted by the surrounding connective tissue cells. 
In the synovial cavities, excess proteins are likely to collect in the potential 
spaces and these must be returned to the circulatory system through the lymphatics, 
otherwise the space swells. Since the synovial membrane offers little or no barrier to 
the transfer of fluid into the surrounding tissues, the protein can flow into the 
lymphatics of the area. 
Classification: 
 Joints are subject to various types of disease and disorders. Disease of joint 
can be classified as follow  
1.Infective arthritis 
Bacterial,viral and parasitic: 
a) Acute infection 
Acute pyogenic arthritis 
Acute gonococcal arthritis 
Acute rheumatic arthritis 
Small pox arthritis 
b) Chronic infections 
Nonspecific : pyogenic arthritis 
Specific          : tuberculous  arthritis 
                         Syphilitic arthritis 
Gonococcal arthritis 
Parasitic         : guinea worm arthritis 
2. Rheumatoid arthropathy 
a) RHEUMATOID ARTHRITIS 
 Rheumatoid Arthritis (Adult) 
Juvenile Rheumatoid Arthritis(JRA) 
b) SERO NEGATIVE SPONDYLO ARTHROPATHY: 
Ankylosing spondylitis 
 Reiter’s Disease 
 Psoriatic arthritis 
 Enteropathic Arthritis 
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3. Degenerative arthritis 
Osteoarthritis 
1. Primary Osteoarthritis 
2. Secondary Osteoarthritis 
4. Neuropathic arthropathy 
 Tables – charcot’sArthropathy 
 Syringomyelia 
 Leprosy 
 Diabetes Mellitus 
5.Metabolic arthritis 
 Gout 
 Alkaptonuric Arthritis 
6.Arthritis in systemic disorder 
 Allergic arthritis 
 Haemophilic Arthritis 
7. Miscellaneous joint 
 Villo – Nodular synovitis 
 Synovial Chondromatosis 
8. Hysterical joint 
ARTHRITIS 
Arthritis is one of the most common joint diseases in India. It owes its causes 
various kinds of prevelling.. Depending  on the total number of joints involved, 
arthritis can be divided into monoarthritis(one joint),oligoarthritis(2 to 4 joints),and 
polyarthritis (5 or more joints).polyarthritis can be  symmetrical or asymmetrical . 
PATHOLOGGY 
Arthritis is an inflammation of one or more joints with involvement of the 
synovium, articular surfaces and capsule. The following stages can be identified: 
 Synovitis 
 Reversible arthritis 
 Irreversible arthritis 
 Ankylosis 
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The cartilage stage of the disease is the involvement and destruction of  the 
articular cartilage, as any gross damage to the cartilage is irreversible, leading to 
ankylosis and loss of function. 
POLYARTHRITIS 
Polyarthritis is involvement of five or more joint groups. In determining the 
cause it is  helpful to consider whether the polyarthritis: 
Symmentrical or as asymmentrical 
 Shows predominant or equal involvement for upper and lower limbs. 
 Shows predominant or equal involvement for large and small joints. 
 Has accompanying particular involvement. 
 Has accompanying extra- articular features as clue to the diagnosis. 
 A defective diagnosis may be difficult in the first few months of onset but 
often becomes firmer as more characteristic features develop with time. 
However , certain patterns are characteristics and may be present at or soon 
after presentation. 
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EXAMPLES OF EXTRA ARTICULAR FEATURES THAT ASSOCIATE   
WITH   INFLAMMATORY OLIGO OR POLY ARTHRITIS: 
Table 3.7 
 
 
Clinical features Disease association 
Skin, nails and mucus membranes 
 Psoriasis, nail pitting and dystrophy 
 Raynaud’s phenomenon 
 Photo sensitivity 
 Liver Reticularis 
 Splinter haemorhages, nail fold infracts. 
 Oral ulcers 
 Large nodules (mainly extensor 
surfaces) 
 Clubbing 
Psoriatic arthritis 
 Scleroderma, lupus 
 Lupus 
 Lupus 
 Vasculites 
Lupus, reactive arthritis, Behcet’s 
 
 Rhematoid arthritis, gout, 
 
EnteropathicArhritis, metastatic 
lung 
cancer, endocardiis. 
 Eye 
 Uveitis  
 Conjunctivitis 
 Episcleritis, scleritis 
 Urethritis  
 
 Seronegativespondyloathritis 
 Reactive arthritis 
 Rheumatoid arthritis  
 Reactive arthritis  
Heart, Lungs  
 Pleuro – pericarditis  
 Fibrosingalveolitis 
 
 Lupus, rheumatoid arthritis  
 Rheuatiod arthritis, lupus, other  
Connective tissue disease. 
Abdominal organs  
 Hepato splenomegaly  
 Haematuria,proteinuria 
 Urethritis  
 
 Rheumatoid arthritis, lupus 
 Lupus, vasculitis, scleroderma 
 Reactive arthritis  
Severe lymphadenopathy   Infection, systemic juvenile 
idiopathic  
Arthritis.  
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A large number of viral infections may cause arthralgia ( Joint pain with no 
abnormal examination findings) and rapid onset of an acute symmetrical 
inflammatory ply arthritis affecting small and large joints of upper and lower limbs 
that is usually self limiting within six weeks.  
 These include parvovirus, hepatitis B and C, mumps, rubella, chickenpox and 
infection mononucleosis. 
 The rapidity of onset, the presence of fever and the characteristic rash usually 
suggest the diagnosis.  
 Arthritis usually precedes jaundice from hepatitis B. 
 Rubella arthritis mainly affects girls and women, occurring 1-7days after the 
rash or 2-6 weeks after vaccination. 
 Rubella is exceptional in that, although the symmetrical poly arthritis settles, 
oligo Arthritis may persist for some months. 
 Poly arthritis that persists for  more than 6 weeks is unlikely to be viral.  
 A definitive diagnosis may be difficult in the first few month  of onset but 
often becomes firmer as more characteristic features develop with time. 
However, certain patterns are characteristic and may be present at or soon 
after presentation.  
 Rheumatoid arthritis is the most common cause of chronic inflammatory, 
symmetrical poly arthritis affecting small and large joints for upper and lower 
limbs. 
 Tenosynovitis and bursitis are the main periarticular manifestation. 
 Marked asymmetry, lower limb predominance and involvement of large more 
than small joint are all more characteristic of sero negative spondylo arthritis. 
Concurrence spondylitis may be further clinical marker of spondyloarthritis. 
 Lupus usually causes more arthralgia and wrist extensor tenosynovitis than 
over synovitis. 
 Chronic poly arthritis due to gout is inevitably preceded by a long history of 
acute attacks. 
 Other causes of poly arthritis are rare. 
 For inflammatory poly arthritis present for less than 6 weeks. 
 The full blood count 
 Liver function tests 
 Viral serology is often appropriate 
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 For early persistant poly arthritis of indeterminate cause appropriate initial 
investigation should include the full blood count. 
 ESR 
 CRP 
 Rheumatoid Factor 
 Antinuclear antibody 
 Radiographs of hand and feet  
CAUSES OF POLYARTHRITIS 
Table 3.8 
Causes Characteristics 
Non inflammatory 
 Generalized osteoarthritis 
 
 
 
 Haemochromatosis 
 Acromegalicarthropathy 
 
 Very common, symmetrical, small 
and large joints, heberden’snodes, 
only a few joints symptomatic at 
any one time. 
 Rare , small and large joints 
 Rare , mainly large joints, spine 
Inflammatory 
 Viral arthritis 
 Rhematoid arthritis 
 
 Seronegativespondarthritis 
 
 Psoriasis 
 
 Reactive 
 
 Ankylosing spondylitis 
 
 Enteropathicarthropathy 
 Lupus 
 Chronic gout, juvenile idiopathic 
arthritis, chronic sarcoidosis, 
scleroderma&Polymyositis, 
hypertrophic osteoarthropathy 
 
 Very acute, self limiting 
 Symmetrical, small and large joints 
upper and lower limbs. 
 Asymmetrical, large> small joints 
lower>uperlimbs, spondylitis 
 Symmetrical,small> large jonts, 
joint damage uncommon. 
 Distal> proximal joints, preceded by 
acute attacks. 
 Symmetrical, small and large joints, 
upper and lower limbs. 
 Symmetrical, smalland large joints. 
 Rare, small and large joints 
 Rare, large> small joints, clubbing. 
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OSTEOARTHRITIS 
Osteoarthritis (OA) is the most common type of arthritis. Its high prevalence, 
especially in the elderly, and the high rate of disability related to disease make It a 
leading cause of disability in the elderly. Commonly affected joints are LS spine, hip, 
knee and MTP. 
Definition 
OA is joint failure, a disease in which all structures of the joint have 
undergone pathologic change, often in concert. The pathologic sine qua non of disease 
is hyaline articular cartilage loss, present in a focal and, initially, nonuniform manner. 
This is accompanied by increasing thickness and sclerosis of the subchondral bony 
plate, by outgrowth of osteophytes at the joint margin, by stretching of the articular 
capsule, by mild synovitis in many affected joints, and by weakness of muscles 
bridging the joint. In knees, meniscal degeneration is part of the disease. There are 
numerous pathways that lead to joint failure, but the initial step is often joint injury in 
the setting of a failure of protective mechamisms. 
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RISK FACTORS  
Figure 3.1 
Intrinsic joint vulnerabilities ( local environment) 
 Previous damage (e.g. meniscetomy) Bridging muscle weakness 
 Increasing bone density, Malalignment, Proprioceptive deficiences 
 
 
 
 
Systemic factors affecting joint vulnerability Use (loading) factors actingon 
joints 
Increased age, female gender, Racial/  Obiesity,Injurious Physical  
activity 
 Ethnic factors genetic susceptibility                               
 Nutritional factors 
 
Osteoarthritis or  
its progression 
 
 
 
PATHOLOGY: 
The pathology of OA provides evidence of the involvement of many joint 
structures in disease. Cartilage initially shows surface fibrillation and irregularity. As 
disease progresses, focal erosions develop there, and these eventually extend down to 
the subjacent bone. With further progression, cartilage erosion down to bone expands 
to involve a large proportion of the joint surface, even though OA remains a focal 
disease with nonuniform loss of cartilage. 
After an injury to cartilage, chondrocytes undergo mitosis and clustering. This 
is because the catabolic activity is greater than the synthetic activity. Collagen matrix 
become damaged, the negative charges of proteoglycans get exposed, and cartilage 
swells from ionic attraction to water molecules. Due to this damaged cartilage 
proteoglycans are no longer forced into close proximity, cartilage does not bounce 
back after loading as it did when healthy and cartilage becomes vulnerable to further 
SUSCEPTIBILITY 
TO 
 OA 
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injury. Stimulate by growth factors and cytokines, osteoblasts in the subchondral bony 
plate, just underneath cartilage, become activated. Bone formation produces a 
thickening and stiffness of the subchondral plate that occurs even before cartilage 
ulcerataes. 
At the margin of the join, near areas of cartilage loss, osteophytes form. These 
are an important radiographic hallmark of OA. The synovium produces lubricating 
fluids that minimize shear stress during motion. In healthy cases the synovium 
consists of fat and two types of cells, marcrophages and fibroblasts, but in OA it can 
sometimes become edematous and inflamed. There is a migration of macrophages 
from the periphery into the tissue, and cells lining the synovium proliferate. 
Additional pathologic changes occur in the capsule, which stretches, becomes 
edematous and can become fibrotic. 
Basic calcium phosphate and calcium pyrophosphate dehydrate crystals are 
present microscopically in most joints with end stage OA. Their role in osteoarthritic 
cartilage is unclear, but their release from cartilage into the joint space and joint fluid 
likely triggers synovial inflammation, which can in turn produce release of enzymes 
and trigger nociceptive stimulation.  
CLINICAL FEATURES 
 Joint pain from OA is activity related. Pain comes on either during or just after 
joint use and then gradually resolves. 
 Early in disease, pain is episodic, triggered often by a day or two of overactive 
use of a diseases joint. 
 Stiffness of the affected joint may be prominent, but morning stiffness is 
usually brief (<30). 
 In knee, bulking may occur, in part due to weakness of muscles crossing the 
joint. 
 Mechanical symptoms such  as bulking, catching or locking, could also signify 
internal derangements. 
 In knees pain with activities requiring knee flexion. 
 Bursitis occurs commonly around knees and hips. 
 OA can be detected by loss of internal rotation on passive movement and pain 
isolated to an area lateral to the hip joint usually reflects the presence of 
trochanteric. 
 Examination of synovial fluid is often more helpful diagnostically han x-ray. 
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RHEUMATOID ARTHRITIS 
Rheumatoid arthritis (RA) is a chronic, multisystem disease affecting the 
connective tissue of the whole body with focal involvement of the musculoskeletal 
system. It causes inflammatory synovitis of peripheral joints, leading to cartilage 
damage, bone errosions and subsequent joint deformity.  
Aetiology 
Aetiology remains unknown. 
 Genetic predisposition 
 Abnormal immune response 
Pathology 
Rhematoid disease in considered to be an autoimmune response to an  
unknown antigen. The antibody formed is the rheumatoid factor which is identified as 
IgM or IgG. Rheumatoid factor may also be present in other conditions such as SLE, 
Sjorgen syndrome, Sarcoidosis and tuberculosis. Other autoantibodies found in RA 
are antibodies to antifilaggrin and anticitrullinated proteins. There is inflammation of 
the synovial membrane, which becomes oedematous and thickened with inflammatory 
exudates. Chronic persistent synovitis is a characteristic features of RA. Microscopic 
examination reveals lymphoid follicle forming nodules with scattered cells. The 
articular tissue gets lysed from the surface. A similar lytic process occurs on the 
deeper surface of the articular cartilage from the granulating lesion in the subchondral 
bone. The inflammatory process spreads into the capsule and the periarticular tissue. 
During the healing process, the granular pannus becomes fibrous, uniting the joint 
surface and causing fibrous ankylosis. The muscles around the jt also undergo 
inflammatory changes in the collagen tissue and get atrophied. Rheumatoid nodules 
which are palpated over bony promininences consist of a central necrotic zone 
surrounded by radially dispersed palisade of local histocyes. 
Figure 3.2 
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Clinical features 
RA is more common in women and occurs between 25 and 40 years of age. It 
is a chronic disease with typically present as symmetric, peripheral, polyarticular 
disease with a  gradual onset. Morning stiffness is very characteristic of RA. RA 
usually involves the small jts of the hands and feet and later spreads to the proximal 
jts such as the knee, hips, elbow and shoulder. 
Joints involved in rheumatoid arthritis 
 Commonly involved joints  
- Small joints of hand, especially MCP and PIP and never DIP joints. 
- Foot especially matatorsophalangeal 
- Wrist 
- Knee and elbow 
- Ankle 
 Less common involved joints 
- Hip 
- TM joint 
- Subtalar joint of foot 
 Rarely involved  
- Upper cervical spine, i.e, interspinous facet jts, atlantoaxial joint 
- Lumbar spine 
- DIP joint of hand 
DEFORMITIES IN RA 
                                                                Figure 3.9 
Joints involved Deformity 
Joints of hand  Ulnar drift 
 Intrinsic plus deformity 
 Boutonniere deformity 
 Swan neck deformity 
Elbow Flexion deformity 
Knee  Early: Flexion deformity 
 Late: Triple subluxation 
Ankle Equinus deformity 
Joints of foot  Hallux valgus 
 Hammer toe 
 Claw toes 
 Callosities 
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DIAGNOSIS 
The picture of bilateral symmetric inflammatory polyarthritis involving small 
and large joints in both the upper and lower extremities suggest the diagnosis. 
Criteria for the diagnosis of rheumatoid arthritis. 
 Mornig stiffness > 1hr 
 Arthritis of 3 or more joints 
 Arthritis of hand joints 
 Symmetric arthritis 
 Rheumatoid nodules 
 Rheumatoid factor 
 Radiological changes 
RADIOLOGICAL FEATURES IN RHEUMATOID ARTHRITIS 
Early changes 
 Soft tissue shadows resulting from swelling 
 Narrowing of joint space 
 Bony erosion 
 Juxta-articular osteopenia 
Later changes 
 Joint dislocation 
 Deformity of joints 
 Subluxation or dislocation of joints 
 Subchondral cystic areas 
SERONEGATIVE SPONDYLOARTHROPATHY 
Seronegativespondyloarthropathy includes the following rheumatoid like 
conditions where the serum is negative for the rheumatoid factor. 
 Ankylosing spondylitis 
 Reiter disease 
 Psoriatic arthritis 
 Enteropathicarthropathy 
ANKYLOSING SPONDYLITIS 
AS is an inflammatory disorder of unknown cause that primarily affects the 
axial skeleton, peripheral joints and extraarticular structures are also frequently 
involved. The disease usually begins in the second or third decade. 
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Clinical manifestations 
The symptoms of the disease are usually first noticed in late early adulthood. 
The initial symptoms is usually dull pain, insidious in onset, felt deep in the lower 
lumbar or gluteal region, accompanied by low back morning stiffness of up to a few 
hours duration that improves with activity and returns following inactivity. Within a 
few months the pain has usually become persistent and bilateral. Nocturnal 
exacerbation of pain often forces the patient to rise and above around. Bony 
tenderness may accompany back pain or stiffness. Common sites include the 
costosternal junctions, spinous process, iliac crests, greater trochanters, 
ischialtuberosities, tibial tubercles and heels. Arthritis in the hips and shoulders occurs 
in 25-35% of patients. Severe isolated hip arthritis or bony chest pain may be the 
presenting complaint. Neck pain and stiffness from involvement of the cervical spine 
are usually relatively late manifestations but are occasionally dominat symptoms. 
The most specific findings involve loss of spinal mobility, with limitation of 
anterior and lateral flexion and extension of the lumbar spine and of chest expansion. 
Limitation of motion is usually out of proportion to the degree of bony ankylosis, 
reflecting muscle spasm secondary to pain and inflammation. Pain in the sarcoilliac 
joints may be elicited either with direct pressure or with stress on the joints. 
Inaddition there is commonly tenderness upon palpation at the sites of symptomatic 
bony tenderness and paraspinous muscle spasm. 
REITER  DISEASE 
It is characterized by a traid of polyarthritis, urethritis and conjuctivities. It is 
an aseptic inflammatory arthritis associated with non specific complaints and at times 
bowel infection. The joint condition is acute polyarthritis resembling RA. It does not 
cause destructive changes in the joint structures. Knee and ankle joints are commonly 
involved. The urethritis is non gnococcal, but the exact organism is not known. 
PSORIATIC ARTHRITIS 
Psoriatic arthritis refers to an inflammatory arthritis that characteristically 
occurs in individual with psoriasis. 
Clinical features 
In 60-70% of cases, psoriasis precedes joint disease. In about 15-20% of cases, 
the arthritis precedes the onset of psoriasis and can present a diagnostic challenge. 
Nail changes in the fingers or toes occur in 90% of patients with PsA, compared with 
40% of psoriatic patients without arthritis and pustular psoriasis is said to be 
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associated with more severe arthritis. Dactylitis occurs in >30% ,enthesitis and 
tenosynovitis are also common. Shortening of digits because of underlying osteolysis 
is particularly characteristic of PsA. Rapid ankylosis of one or more proximal 
interphalangeal (PIP) joints early in the course of disease is not uncommon. Back and 
neck pain and stiffness are also common. 
ENTEROPATHIC ARTHROPATHY   
Chronic inflammation bowel diseases such as regional enteritis and ulcerative 
colitis are associated with arthriti lesions in about 10% cases. There is peripheral 
polyarthritis or involvement of the spine. The joint conditions shows remissions and 
exacerbations along with the activity of the underlying bowel disease. The joint 
disease usually resolves with the treatment of the bowel disease. 
REACTIVE ARTHRITIS 
ReA refers to acute nonpurulent arthritis complicating an infection elsewhere 
in the body. Constitutional symptoms are common, including fatigue, malaise, fever 
and weight loss. Arthritis is usually asymmetric and addictive with involvement of 
new joints occurring over a few days 1-2weeks. The joints of lower extremities are 
most commonly involved, but the wrist and fingers can be involved as well. The 
arthritis is usually quite painful, and tense joint effusions are not uncommon, 
especially in knee. Patiemts often cannot walk without support. 
Spinal and low back pain are common and may be caused by insertional 
inflammation, muscle spasm, acute sacroilitis or presumably, arthritis in intervertebral 
joints. Ocular disease is common. Mucocutaneouslesion are frequent. 
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DIAGNOSIS OF ARTHRITIS 
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Septic Arthritis 
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MATERIALS AND METHOD 
Clinical study on Santhuvatham was carried out in the Post graduate 
SirappuMaruthuvam department of Government Siddha Medical College, 
Palayamkottai. In this study 40 patients (who satisfy the inclusion criteria and 
exclusion criteria) were treated as OP and IP patients. The clinical trial was duely 
approved by the Institutional Ethics Committee (IEC), Government Siddha Medical 
College, Palayamkottai. 
SAMPLE SIZE : 
 40 patients ( OPD& IPD) 
STUDY DESIGN & CONDUCT OF STUDY:  
Study type  :  prospective open labelled phase II  clinical 
criteria based study . 
Study Place :  OPD & IPD of Government Siddha medical College 
& hospital,   Palayamkottai. 
Study Period :  24 Months  
Sample Size :  40 Patients ( OPD& IPD). 
 
PRIMARY STUDY END POINTS: 
 The primary endpoints to be measured in this study include  
 X-rays will be taken once in two weeks and assessed for improvement.  
 Urine and blood samples will be collected once in two weeks and analyzed. 
 The prognosis of inflammation will be measured by a measuring tape,twice in 
a week.  
 Number of visit to the OPD will be noted.patient will be asked to come to 
OPD weekly thrice. (Monday, Wednesday &Friday) for 6 weeks. 
SECONDARY STUDY END POINTS: 
 The secondary endpoint to be measured is evaluated relief in symptoms in 
subjects under study 3 times at weeks. 
PRIMARY SAFETY END POINTS:  
 The primary safety endpoint will be measured and collection of any serious 
adverse event that occurs from initial study treatment through and including 30 days 
after cessation of study treatment. 
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INCLUSION CRITERIA: 
 Age   :  between 20- 70 years  
 Sex  : Both male and female 
 Joints pain : more than 5 joints 
 Swelling   
 Stiffness  
 Restricted movements in affected joint.  
 Willing for admission and study in IPD for 30-40 days or willing to attend 
OPD 
EXCLUSION CRITERIA: 
 Rheumatic Fever 
 Rheumatoid arthritis 
 Other systemic illness 
 Gout  
 Recent Fracture  
  Recent Dislocation of joints 
 Malignancy  
 Use of narcotic drugs  
 Pregnancy and Lactation  
 Tuberculosis  
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of adverse reactions during drug trial. 
 Poor patient’s compliance and defaulters. 
 Patient turned unwilling to continue in the course of clinical trial.  
 Occurrence of any serious illness.  
TESTS AND ASSESMENTS: 
 Clinical assessment  
 Routine investigations 
 Specific investigations 
 Radiological investigations 
 Siddha investigations 
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CLINICAL ASSESSMENT: 
 Pain in more than five  joints 
 Tenderness, Numbness  
 Stiffness  
 Restriction of movements of  affected joints 
 Effect of treatment will be evaluated on the basis of changes in the signs and 
symptoms after the treatment. 
PAIN ASSESSMENT  
UNIVERSAL PAIN ASSESSMENT SCALE  
0 1 2 3 4 5 6 7 8 9 10 
A.0 : No Pain  
B. 1-3  : Mild pain  
C.4-6 : Moderate pain 
D.7-10 : Severe pain  
Reference: Clinical Manual for Nursing Practice. (National Institute of Heatlth 
Warren Grant Magnuson Clinical center 
GRADATION: 
Grade 1: Fit for all activities to do their work without support (Normal)  
Grade 2: Mild Pain and Mild restriction of Movements  
Grade 3: Moderate Pain and Moderate restriction of Movements  
Grade 4: Severe Pain and Severe restriction of Movement  
Investigations 
 The symptoms of santhuvatham were more or less correlated with polyarthritic 
conditions of (Rheumatological and collagen diseases) in modern medicine.  So 
investigations meant for such diseases were done for santhuvatham. Some of these are 
routine blood tests, urine tests, stool examination and specific tests such as 
rheumatoid arthritis factor, radiographic evaluation etc.  Besides this blood sugar, 
blood urea, serum cholesterol were also investigated. The diagnosis was made by 
following Siddha diagnostic methods. Nilam, Kalam, Poriyalaridhal, Pulanalarithal, 
Vinaadhal, MukkutraNilaigal ,UdalThathukal and EnvagaiThervugal, and the 
diagnosis of Santhuvatham were obtained which correlated with modern diagnosis of 
Polyarthritis by the X-Ray findings.  
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INVESTIGATION: 
 The following investigations were done in all selected patients in the 
laboratory of Government Siddha Medical College, Palayamkottai. 
BLOOD: 
TC  (Cells/cu mm)  
DC P     L   E    M   N 
ESR ½ hr  1hr 
Hb  g% 
Blood Sugar: 
 Fasting  
 Post prandial 
Renal function tests:  
 Blood urea 
 Blood uric acid 
 Serum creatinine 
Serology:  
 C-reactive protein  
 RA factor   
 ASO titre 
Urine examination:  
 Albumin 
 Sugar 
Deposits. 
RADIOLOGICAL INVESTIGATIONS:  
 X-Ray of affected jonts (AP and Lateral view). 
TREATMENT : 
 Vellaiennai 15ml at morning with hot water was given on the first day of 
treatment. 
INTERNAL: 
Drug: Kodivelichooranam 
REFERENCE: 
 Yugivaithiyakaviyam, (page no-19,20)  DOSE:500-800 mg, thrice a day. 
ADJUVANT: 
 Ghee  
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DURATION: 
30-40 days. 
EXTERNALDRUG: 
 Thirugukalli Ennai 
REFERENCE: 
 Yugivaithiyakaviyam, (page no-20) 
OTRADAM 
DRUG: 
 Murnugaisurasa otradam 
REFERENCE: 
 Yugivaithiyakaviyam (page- 40) 
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RESULTS AND OBSERVATION 
 For the clinical study 40 patients were selected and treated in PG-III 
SirappuMaruthuvam Department, GSMC hospital, Palayamkottai.  Results were 
observed with respect to the following criteria. 
1. Gender distribution 
2. Age distribution 
3.   Kalam 
4. Occupation 
5. Seasonal variation 
6. Thinai 
7. Socioeconomic factors 
8. Gunam 
9. Disturbance in vatha 
10. Disturbance in pitha 
11. Disturbance in kapha 
12. Udalthathukkal 
13. Envagaithervu 
14. Naadi 
15. Neikuri 
16. Distribution of illness 
17. Clinical manifestation 
18. Locomotar system 
19. Joint involvement 
20. Improvement 
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OBSERVATION AND RESULTS 
1.GENDER DISTRIBUTION  
Table 5.1 
S.NO Gender No. Of Cases Percentage 
1 Male 8 20 
2 Female 32 80 
 Total 40 100 
 
 
 
 
Inference : 
Among 40 patients selected for this study 80% are female and 20% are male. 
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2.AGE DISTRIBUTION 
Table 5.2 
S.NO Age in year No. of cases Percentage 
1. 20- 30 1 2.5 
2. 31-40 6 15 
3. 41-50 14 35 
4. 51-60 19 47.5 
 Total 40 100 
 
 
 
 
Inference: 
The prevalence of the disease is found to be higher in the age group of 51- 60. 
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3.KAALAM 
TABLE  5.3 
 
S.NO Kaalam No. of cases Percentage 
1. Vathakalam ( upto 33 yrs) 1 2.5 
2. Pithakalam ( 34- 66yrs) 39 97.5 
3. Kabakalam ( 67- 99yrs) 0 0 
 Total 40 100 
 
 
 
Inference: 
Out of 40 cases, 97.5% of cases were founded to be in Pithakalam. 2.5% of 
cases were found to be in Vathakaalam. 
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4.OCCUPATION 
TABLE 5.4 
 
 
 
 
Inference: 
65%  has been household, 7.5% has been labour 
12.5% has been farmer, 2.5% has been student,tailor business and watch man  
5% has been office worker 
 
 
S.NO Occupation No. of cases Percentage 
1. Farmer 5 12.5 
2. House wife 26 65 
3. Labour 3 7.5 
4. Student 1 2.5 
5. Business man 1 2.5 
6. Office worker 2 5 
7. Tailor 1 2.5 
8. Watch man 1 2.5 
 Total 40 100 
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5. SEASONAL VARIATION 
TABLE 5.5 
S.NO. SEASON 
NO OF 
CASES 
PERCENTAGE % 
1 Kaarkaalam  - Aavani, Purattasi 
(15 Aug -  14 Oct ) 
3 7.5 
2 Koothirkaalam - Iyppasi, Karthigai 
(15 Oct -  14 Dec) 
4 10 
3 Mupanikaalam - Markazhi, thai 
(15 Dec – 14 Feb) 
4 10 
4 Pinpanikaalam – Masi, Panguni 
(15 Feb – 14 Apr) 
11 27.5 
5 Ilavenirkaalam - Chithirai, vaikasi 
(15 Apr – 14 June) 
8 20 
6 Muthuvenirkaalam-aani ,aadi (15 June-
14 Aug) 
10 25 
 
 
 
Inference: 
Out of 40 cases 27% patients were admitted in pinpanikaalam, 25% of 
patients were admitted in Muthuvenirkaalam, 20% patients were admitted in 
Elavenirkaalm,1 0% of patients were admitted in Koothirkaalam, 10% of patients 
were admitted in munpanikaalam, 7% of patients were admitted in Karkaalam.  
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6. THINAI 
Table 5.6 
S.NO. THINAI NO OF CASES PERCENTAGE 
1 KURINJI 0 0 
2 MULLAI 0 0 
3 MARUTHAM 32 80 
4 NEITHAL 8 20 
5 PALAI 0 0 
 
 
 
Inference: 
Among 40 cases, majority were from MaruthaNilam( 80%). 
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7. SOCIO ECONOMIC STATUS 
TABLE5.7 
S.NO 
SOCIO ECONOMIC 
STATUS 
NO OF CASES PERCENTAGE 
1 POOR 13 32.5 % 
2 MIDDLE CLASS 25 62.5% 
3 RICH 2 5 % 
 
 
 
Inference: 
 The above study consists of 62.5% of cases from middle class, 32% of cases 
from poor and 5% of rich. 
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8. GUNAM 
TABLE 5.8 
S.NO. GUNAM NO OF CASES PERCENTAGE % 
1 SATHUVA 0 0 
2 RASO 38 95 
3 THAMO 2 5 
 
            
Inference: 
 About 0% of the patients had Sathuvagunam 
 95% of the patients had Rasogunam 
 5% of the patients  had Thamogunam 
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DISTURBANCES  IN VATHAM  
Table  5.9 
S.NO VATHAM NO OF CASES PERCENTAGE 
1 PRANAN 0 0 
2 ABANAN 11 27.5% 
3 VYANAN 40 100 % 
4 SAMANAN 40 100  % 
5 UTHANAN 0 0 
6 NAGAN 0 0 
7 KOORMAN 0 0 
8 KIRUGARAN 0 0 
9 DHEVATHAHAN 20 50 
10 DHANAJEYAN 0 0 
 
 
Inference: 
 Viyanan & Samanan were affected in all cases (100%). Abanan were affected 
in 27.5% cases, Dhevethathan were affected in 50%. 
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DISTURBANCE IN PITHAM 
TABLE 5.10 
S.NO PITHAM NO OF CASES PERCENTAGE% 
1 Anarpitham 10 25% 
2 Ranjagam 6 15% 
3 Prasagam 0 0 
4 Alosagam 0 0 
5 Saathagam 40 100 % 
 
 
Inference: 
Sathagapitham was affected in all the 40 cases (100%). Ranjagapitham was 
affected in 15% cases,Anarpitham was affected in 25% cases. 
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DISTURBANCE IN KABAM 
TABEL 5.11 
S.NO KABHAM NO OF CASES PERCENTAGE% 
1 Avalambagam 40 100 
2 Kilethagam 0 0 
3 Pothagam 0 0 
4 Tharpagam 0 0 
5 Santhigam 40 100 % 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference: 
Among all,Avalambagam andSanthiagamwas affected in all 40 cases (100%). 
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DISTURBANCE IN UDAL KATTUKAL 
TABLE 5.12 
S.NO. UDAL KATTUKAL NO OF CASES PERCENTAGE% 
1 Saaram 10 25% 
2 Senner 7 17.5% 
3 Oon 0 0% 
4 Kozhuppu 12 30% 
5 Enbu 40 100% 
6 Moolai 0 0% 
7 Sukkilam/Suronitham 0 0 
 
  
 
Inference: 
 In 7 udalkattukal , 100% was Enbu affected(restricted in joint movement),25% 
was saaram affected (loss of strength to body),30% was kozhuppu was 
affected(movement restriction) ,17.5% senner was affected(low energy). 
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DISTURBANCE OF ENN VAGAI THERVU 
TABLE 5.13 
S.No. Envagaithervugal Number of cases Percentage% 
1. Naadi 40 100 
2. Sparisam 0 0 
3. Naa 7 17.5 
4. Niram 4 10 
5. Mozhi 0 0 
6. Vizhi 0 0 
7. Malam 9 22.5 
8. Moothiram 0 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference: 
 It was learnt during the study that naadi was noted in all 40 cases( 100%). 
Malam was affected in 9 (22.5%). 
 
 
 
 
 
 
Disturbance in Enn vagai thervugal
Naadi
Sparisam
Naa
Niram
Mozhi
Vizhi
Malam
Moothiram
74 
 
ILLUSTRATION OF NAADI 
TABLE 5.14 
S.No. Parameters Number of cases Percentage 
1. Vathapitham 29 72.5 
2. Vathakabam 6 15 
3. Pithavatham 5 12.5 
 
 
 
Inference: 
As mentioned above thonthanaadi was noted in all cases and among them 29% 
were  vathapithanadi,  15% were vathakabhanadi and remaining 12.5% were 
pithavathanadi. 
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NEIKURI 
TABLE 5.15 
S.NO SPREADING PATTERNS NO OF CASES PERCENTAGE% 
1 Snake 21 52.5 
2 Ring 11 27.5 
3 Pearl 8 20 
 
 
 
Inference 
 In neikuri analysis,  52.5% of the cases presented with Vathaneer, 27.5% with 
pithaneer, 20% with kabaneer. 
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DURATION OF ILLNESS 
TABLE 5.16 
S.No. Duration of illness 
(Months) 
Number of 
cases 
Percentage 
(%) 
1. 0-3 24 60 
2. 4-6 11 27.5 
3. 7-12 3 7.5 
4. 13-24 1 2.5 
5. Above 24 1 2.5 
 
 
 
 
Inference: 
In duration of illness, 60% occur  upto 3 months, 27.5%  occur in 4-6 months, 
7.5% occur in 7-12 months,  2.5% occur in13-24 months, 2.5% occur in Above 24 
months. 
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CLINICAL MANIFESTATIONS 
TABLE 5.17 
S.NO SYMPTOMS 
BEFORE TREATMENT AFTER  TREATMENT 
NO OF 
CASES% 
PERCENTAGE% 
NO OF 
CASES 
PERCENTAGE% 
 
1. Joint pain 40 100 4 10 
2. Swelling 12 30 0 0 
3. Morning 
stiffness 
25 62.5 2 5 
4. Restricted to 
walk 
20 50 1 2.5 
5. Difficulty to 
walk 
12 30 1 2.5 
6. Neck pain 8 20 0 0 
7. Difficulty in 
chewing 
0 0 0 0 
8. Fever 0 0 0 0 
9. Sleeplessness 23 57.5 5 12.5 
10. Loss of 
appetite 
20 50 2 5 
11. Loss of 
weight 
0 0 0 0 
12. Constipation 12 30 1 2.5 
13. Easy 
fatiguability 
18 45 4 10 
78 
 
 
 
Inference: 
Before treatment 100% of cases had pain, 30% of cases has difficulty to walk, 
62.5% of cases had morning stiffness, 50% if cases had restricted to walk, 57.5% of 
cases had sleeplessness,30% of cases had swelling and 50% of cases had loss of 
appetite, 45% of cases had easy fatiguability and 30% has constipation. 
 After treatment 10% of cases had pain,5% cases had morning stiffness,  loss of 
appetite. 10% of cases had easy fatiguability,2.5% cases had restricted and difficulty 
to walk. 0%  cases had swelling, 2.5% of cases had constipation. 
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LOCOMOTOR SYSTEM 
TABLE 5.18 
S.NO 
INVOLVEMENT OF 
UPPER AND LOWER 
EXTREMITIES 
NO OF CASES PERCENTAGE % 
1 Upper extremity 30 75 
2 Lower extremity 36 90 
3 Both upper and lower 
extremity 
31 77.5 
 
 
  
Inference 
 90% cases show lower extremity, 75% cases show upper extremity and 77.5% 
cases show both 
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INCIDENCE OF INDIVUDUAL JOINT INVOLVEMENT 
Table 5.19 
S.NO JOINT INVOLEMENT NO OF CASES PERCENTAGE % 
1. Wrist joint 8 20 
2. Elbow joint 12 30 
3. Shoulder joint 23 57.5 
4. Lumbosacral joint 26 65 
5. Minor joints in upper 
&lower limb 
13 32.5 
6. Cervical spine 14 35 
7. Hip joint 11 27.5 
8. Knee joint 36 90 
9. Ankle joint 12 30 
 
  
Inference 
 100% cases show pain in knee joint 26% cases show pain in lumbo sacral 
joint, 11% cases show pain in hip joint an ankle joint, 23% cases show pain in 
shoulder , 8% cases show pain inwrist joints, 15% cases show pain in elbow joint, 
14% cases show pain in cervical spine.13% case show pain in minor joints in upper 
and lower limb. 
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ASSESSMENT OF CURATIVE EFFECTS IN PATIENTS TREATED WITH 
TRIAL DRUGS (INTERNAL AND EXTERNAL MEDICINES WITH 
THERAPY) 
Table 5.20 
S.NO 
BEFORE TREATMENT AFTER TREATMENT 
SYMPTOMS NO OF CASES SYMPTOMS 
NO OF 
CASES 
1. Mild 5 No pain 5 
   Mild 0 
   Moderate 0 
   Severe 0 
2. Moderate 6 No pain 4 
   Mild 0 
   Moderate 2 
   Severe 0 
3. Severe 9 No pain 4 
   Mild 2 
   Moderate 3 
   Severe 0 
 
 
 
 
 
 
 
 
 
 
Inference 
From the above study, it was inferred that severe pain that was noted in 
patients before treatment had a remarkable decline after treatment similarly moderate 
and mild pain were also observed to have decreased after treatment. 
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DISCUSSION 
 The main aim of the treatment was to study the Therapeutic effect of the drug 
KODIVELI CHOORANAM to reduce pain, swelling and restricted joint movements 
in the disease Santhuvatham. The clinical features of Santhuvatham can be correlated 
to Polyarthritis in modern science. Polyarthritis is a chronic inflammatory disease 
associated with symmetrical or asymmetrical involvement of joints. After 
conformation of the diagnosis of the trail drug was administrated along with the 
special therapies. Observation were noted and analysed. They are discussed here 
under. 
Sex distribution 
 According to the Gender among the 40 patients selected, the disease was 
found to be higher in females 80% and in males 20%. 
Age distribution  
The statistical study shows high incidence of santhuvatham in the age group 
between 51-60 years and lowest incidence in the age between 20-30 years.  
 Most of the patients belong to pithakalam. 
Paruvakalam 
 In Paruvakaalam(Season) out of 40 cases, 10%cases were included in 
Munpanikaalam, 27.5% cases were Pinpanikaalam and 7.5% were kaarkalam, 7.5% 
cases were koothirkaalam, 25% cases were muthuvenirkaalam. 
Gunam 
 Based on Gunam out of 40 cases 100% were Rasogunam. 
Thinai 
 In Thinai out of 40 cases 80% cases were from MaruthaNilam,20% were from 
Neithal Nilam. 
Socio economic status 
 In Socio economic status out of 40 cases, 62.5% cases belonged to Middle 
Class, 32.5% cases belonged to Poor, 5% cases belonged to Rich. 
Occupation 
In occupational distribution out of 40 cases, 65% were household,7.5% were  
labour 12.5% were farmer, 2.5% were student,tailor business and watch man 5% were 
office worker. 
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Disturbance in vatham 
In Vatham out of 40 cases, 100% cases were affected in Samaanan and 
Viyaanan, 27.5% cases were affected in Abanan, 
Disturbance in pitham 
 In Pitham out of 40 cases, Saathagam was affected in 100% cases. Anarpitham 
was affected in 25% cases and Ranjagam was affected in 15% cases. 
Disturbance in kabam  
 In Kabam out of 40 cases, Santhigam was affected in 100% . 
Udal thathukal  
 In 7 udal kattukal, 100% was Enbu affected(restricted in joint movement), 
25% was saaram affected (loss of strength to body),30% was kozhuppu was 
affected(movement restriction) ,17.5% senner was affected(low energy). 
En vagai thervu 
In Envagaithervugal among the 40 cases,  100% was thontha naadi,17.5% naa 
were affected and 22.5% seen in malam. 
Naadi 
While seeing the Naadi among the 40 cases PithaVaathanaadi was found in 
10%, VaathaPithanaadi was found 82.5% cases and VaathaKabam was found in 
7.5%cases. 
Neikuri 
 In Neikkuri, among the 40 cases,52.5% of the case showed snake pattern 
27.5% of the case showed ring pattern and 20% shows pearl pattern. 
Duration of illness 
 In Duration of illness out of 40 cases, 60% were occur in 3 months, 27.5%  
occur in  4-6 months, and 7.5% occur in 7-12 months and 2.5% occur in 13-24 
months,2.5% occur  in above 24 months. 
 100% cases show pain in knee joint 26% cases show pain in lumbo sacral 
joint, 11% cases show pain in hip joint an ankle joint, 23% cases show pain in 
shoulder , 8% cases show pain inwrist joints, 15% cases show pain in elbow joint, 
14% cases show pain in cervical spine.13% case show pain in minor joints in upper 
and lower limb. 
  
 
90 
 
Clinical manifestation 
Before treatment 100% of cases had pain, 30% of cases has difficulty to walk, 
62.5% of cases had morning stiffness, 50% if cases had restricted to walk, 57.5% of 
cases had sleeplessness,30% of cases had swelling and 50% of cases had loss of 
appetite, 45% of cases had easy fatiguability and 30% has constipation. 
Locomotor system 
 In Locomotor system the Lower extremity was affected in 90% cases, Upper 
extremity was affected in 75% cases and both was affected in 77.5% cases. 
Improvement 
 Overall Result in my study - 70% cases showed Good improvement, 20% 
cases showed Moderate improvement, 10% cases showed Mild improvement. 
Investigation 
 Laboratory investigation of blood and urine were done for all 40 cases. There 
were significant changes in blood before and after treatment. Rheumatoid arthritis 
factor was negative in all cases. Blood sugar, blood urea and serum cholesterol were 
done. The values were found to be normal in all the cases. 
Pre clinical studies 
The phytochemical study of  KODIVELI CHOORANAM had revealed the 
presence of Calcium, Sulphate, Starch, tannic acid, unsaturated compound and amino 
acid. 
Pharmacological studies 
The pharmacological studies done in KODIVELI CHOORANAM revealed 
that the presence of action such as ANTI INFLAMMATORY and ANALGESIC. 
Toxicity study 
Acute toxicity study in rats for KODIVELI CHOORANAM revealed that it 
has no toxicity effect. 
Treatment 
The treatment was aimed to retain the deranged thoshas and providing relief 
from symptoms. Before treatment the patients were advised to take vellai ennai-15ml 
with hot water during morning for first day of treatment. 
From the second day onwards internal medicine KODIVEL CHOORANAM 
500-800 mg twice a day after food and THIRUGUKALLI ENNAI is given as 
external. 
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At the time of treatment patient were advised to follow pathiyam and 
specifically advised to avoid foods which increase vadha. 
Along with the course of treatment the complementary therapy fomentation 
was given additionally to every patient. 
The outcome of this study is mainly assessed by reduction of pain in all joints, 
increased range of reduction of restricted movements and improvement in quality of 
life. Universal pain assessment scale was also used to detect proper outcome. No 
adverse effect wasnoted for both internal and external medicine along with the course 
of treatment. 
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SUMMARY 
 A collective study of the disease Santhuvatham is made covering the all 
aspects of the disease enclosing siddha and modern science aspects  .Study drug 
standardised are botanical, pharmacological, biochemical and toxicological, these are 
supportive of trial drug for our santhuvatham.40 cases with santhuvatham were 
diagnosed clinically, every patients have received otradam and observed for clinical 
diagnosis, Lab Investigations and treatment of trial medicines.The peak age incidence 
of Santhuvatham was found 51-60 years age group.Clinical diagnosis of the above 
disease was done on the basis of clinical features described in  
YugiVaidhyaChinthamani and Siddha Maruthuvam.Before admission for study their 
careful detailed history of the sufferings, duration, their occupation, native etc. are 
elicited from the 40 selected patients.The trial medicines for the clinical treatment and 
management of Santhuvatham were KODIVELI CHOORANAM, twice a day with 
ghee and for external use THIUGUKALLI ENNAI. External therpyotradam had 
effective. Biochemical analysis ofKDIVELI  CHOORANAM showed that the 
presence of Calcium, Sulphate, Starch, tannic acid, unsaturated compound and amino 
acid. The pharmacological study, the toxicological studies were done.During 
treatment, all the patients keep under strict pathiyam, a specific dietary regimen, it has 
been clearly mentioned in review of siddha literature.No any adverse effect of study 
drugs. All the patients were advised to exercise regularly.The observation made 
during the clinical study shows that the main drugs KODIVELI  CHOORANAM is  
conducive. 
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CONCLUSION 
 Now a daysSanthuvatham is more common causing social burden to families. 
The physiochemical analysis reveals that the trial drug contains important constituents 
which have beneficiary effects in arthritis. 
The Toxicological studies reveal that the trial drug did not produce any 
toxicity in rat models.The Preclinical studies reveals that the trial drug hasanti 
inflammatoryand  analgesic action .The clinical study shows significant decrease in 
the symptoms of the disease.The trial drug gives a good confidence in the 
management of Santhuvatham and economicaly very low cost.No contra indications 
was noted during the course of treatment.Finally the author conclude that the trial 
drug KODIVELI  CHOORANAM and THIRUGUKALLI ENNAI  is effective in 
SANTHUVATHAM.along with therapy(Otradam).  For more results further studies 
should be continued in this. 
 
 
 
 
 
 
94 
 
ANNEXURE 1 
PREPARATION AND PROPERTIES OF TRAIL DRUG 
INTERNAL DRUG – KODIVELI CHOORANAM 
Refernce- YUGI VAITHIYA KAVIYAM 
Ingredients: 
 Omam  - Carum copticum    35g 
 Kodiveli  - Plumbago indica   35g 
Indhuppu  - Sodium chloride impure/Rock salt 35g 
Perungayam - Ferula asafetida   35g 
Koshtam - Saussurea costus   35g 
Chukku - Zingiber officinalis   35g 
Sandhanam - Santalum album    35g 
Devatharam - Cedrus deodara    35g 
Thipili  - Piper longum    35g 
Imbural - Oldenlandia umbellata  35g 
Vasambu - Acorus calamus    35g 
Karunjeragam - Nigella sativa     35g 
Maruthondri - Lawsonia inermis    35g 
DOSE  - 790mg  twice a day 
ADJUVANT - Ghee 
DURATION - 30-40 days. 
 
STANDARD OPERATING PROCEDURE 
Source of raw drugs 
 The required drugs for preparation of KODIVELI CHOORANAM(internal)  
and THIRUGUKALLI ENNAI (external)  would be purchased from a well reputed 
country shop  and standardized before preparing medicines. This raw drug would be 
authenticates and then they were  purified and the medicines were prepared in 
Gunapadam laboratory of Government Siddha Medical College, Palayamkottai. 
PURIFICATION OF RAW DRUGS:  
Chithiriramoolam ver 
 The root will be baked in steam of milk. 
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Thippili 
 Remove the adulterant and allow it to dry. 
Indhu uppu 
 Soaked in kaadi neer in 3 days,keep under sunlight ,then dry it. 
Chukku 
Dried ginger, washed it and the outer skin is removed and collected. 
Preparation: 
The above mentioned drugs are purified properly as said above and they are 
dried in shade and made into fine powder. 
Drug storage: 
The trial drug Kodiveli chooranam is stored in a clean and dry air tight 
container and it is dispensed to the patients in packets. 
EXTERNAL MEDICINE: 
THIRUGUKALLI ENNAI 
Referance : Yugi Vaithiya Kaviyam 
Thirugukalli             -  Euphorbia tirucalli         - 560g 
Neem oil                   - Azadirecta indica           - 1.3 l 
Preparation : 
Make decoction of thirugukalli with water and add neem oil to that decoction 
and boil it again and filtered and keep it  in a container.It can be used as an external 
application which cure all vadha diseases. 
Drug storage:  
 The trial drug is stored in clean dry air tight container and it is given to the 
patients in disposable pet bottles. 
EXTERNAL THERAPHY: 
MURUNGAI SURASA OTRADAM 
 Ingredients: 
Murungai leaf  -  Moringa oleifera 
Garlic   -  Allium sativum 
Perungayam  -  Ferula asafotida 
Milagu  - Piper nigra          
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Preparation: 
Take equal amount of murungai leaf,coconut slice.pepper,garlic and fried it 
and add asafoetida to it. 
GUNAPADAM ASPECT 
INTERNAL MEDICINE  : KODIVELI  CHOORANAM 
1.Tamil name  - Xkk;  
Botanical name  - Carum copticum                                      
English name  - The Bishops weed 
Family  -  Apiaceae 
Parts used   - Seed            
Rit - fhh;g;G. jd;ik - ntg;gk;> gphpT - fhh;g;G  
nghJFzk;  
 Rj;Ruq; fhrQ; nrhpahke; jk;nghUky; 
Ngjpapiur; ry;fLg;G Nguhkk; - XjpUky; 
 gy;nyhLgy; %yk; gfkpitNeh nad;nrANkh? 
 nrhy;nyhLNghk; Xknkdr; nrhy;. 
        (m.F) 
 ,jdhy; IaRuk;> nrhpahkhe;jk;> nghUky;> Flypiur;ry;> gfk; 
(Fa;aNuhfk;) ,itfs; Nghk;. 
2.Tamil name  - nfhbNtyp 
Botanical name - plumbago zeylanica 
English name       – ceylon lead wort 
Family                  - plumbaginaceae 
Parts used             - root 
Rit - fhh;g;G> jd;ik - ntg;gk;> gphpT - fhh;g;G  
nghJFzk; : 
 fl;btpu zq;fpue;jp fhy;fs; miuahg;Gf; 
 fl;br;# iytPf;fq; fho;%yk; - Kl;buj;jf;  
 fl;LeP Nuw;wq; fdj;j ngUtapWk;  
 ml;Lq; nfhbNtyp ahk;.  
                                  (m.F 
,jdhy; fl;b> Gz;> foiy> tsp Neha;> miuahg;Gf;fl;b> Fj;jy;> Nrhig> 
ePNuw;wk;> ngUtapW ,itNghk;. 
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fl;bNa R+iyf;fl;L fUjpL Fwpg;Gz; fpue;jp 
 xl;LNk fhuzj;NjhL KWkiu ahg;G kd;wp  
 tpl;blh newpr;R uk;gpd; tpad;tpl kr;R ue;jhd; 
 nghl;nldg; gwe;J NghFk; Gfo;nfhb Ntyp fz;lhy; (VL) 
,d;Dk; ,jdhy;> R+iyf;fl;L> newpRuk;> er;RrPruk; KjypaitAe; jPUk; 
Constituents: 
 Plumbagin I, Isohinanolone II, Plmbagic acid III, Beta sitosterol,  
transcinngemic acid, Vanillic acid. 
Action : 
Anti periodic 
Diaphoretic 
Root: 
 Digestive power & promote the appetite. 
3.Tamil name  - ngUq;fhak; 
English name  – Asafoetida 
Botanical name - Ferula asafoetida 
Fmaily  - Apiaceae 
Parts used  - Resin 
Rit - ifg;G> fufug;G / jd;ik - ntg;gk; gphpT - fhh;g;G 
nghJFzk;: 
 je;jNt je;j %yj;njOk;gpzp 
  rUtfhsk; tpUr;rpfq;fPlk;kh 
 ke;jk;thjk; cjhth;j;jk; my;Fy;Neha; 
  khh;gzq;fl;l Fd;kk;kNfhjuk; 
 ce;Jnfh;g;ge;jpd tpj;jpuQ;R+iyr;R+h; 
  cjpug;G+r;rp rpNyj;Jkj;JWk;typ 
 te;jnka;f;fLg; NghbitKw;WNk 
  khAehWew; fhaq;fpilf;fpNd           (Nj.F) 
,jdhy; ke;jk;> Vg;gk;> thjk;> #jfthA> Fd;kk;> ngUtapW> #jfr;R+iy> 
FUjpapYs;s Ez;GO> Iaj;jhy; gpwe;j typfs; cly; fLg;G> vd;Dk;k 
,itfs;. 
4.Tamil name  :  Nfh\;lk; 
Botanical name :  Saussurea costus 
English name  :  Costus Root 
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Family  :  Asteraceae 
Parts used   :  Root 
Action    : Tonic, Stimulant, Stomachic 
Rit - ifg;G> tpWtpWg;G Æ jd;ik - ntg;gk; Æ gphpT - fhh;g;G 
nghJFzk;  
 ehl;bYW ntl;il eLf;fk; vDNeha;fs;  
 Nfhl;lnkdr; nrhd;dhy; FiyAq;fhz; - $l;bw; 
 RuNjhle; njhz;il Neha; Njhyhj gpj;jk; 
 guNjrk; NghNk gwe;J  
          (m.F) 
 jpl;bfTs; mfLfsQ; nrd;dp ehtha; 
  nrwpgpzpntg; gijg;Gjh th;j;jk; Cij 
 Kl;bnaO Kistpuzk; Rthr fhrk; 
  %bfj;Njh luTku tplq;fs; Nkff; 
 fl;bm[ fy;yptpl ghfk; G+j 
  fzk;ghy fpufnkhL jhJ el;lQ; 
 nrhl;btU gpukpgpj;jk; ,itnahUq;Nf 
  njhiyAk; tpu zhhpf;Fr; Rfg; NghwhNk 
          (Nj.F) 
 ,jdhy; fz;> jhil> tapW> fOj;J> jiy> eh> tha;> 
,t;tplj;jpYz;lhFk; Neha;fs;> Ruk;> mijg;G> thA> %yKis> Nkff;fl;b> 
gapj;jpak; ,it Nghk;. 
5.Tamil name  -   Rf;F 
English name  –   Dried Ginger 
Botanical name -   Zingiber ooficinale 
Family  -   Zingiberaceae 
Parts used  -  Rhizome 
Action   - Stimulant, Stomachic, Carminative  
Rit - fhh;G Æ jd;ik - ntg;gk;> gphpT - fhh;g;G  
nghJFzk;  
 #iyke;jk; neQ;rhpg;G NjhlNkg; gk;kioiy 
 %yk; ,iug;gpUky; %f;FePh; - thyfg 
 Njhlkjp rhue; njhlh;thj Fd;kePh;j; 
 Njhlk;M> kk;Nghf;FQ; Rf;F 
          (m.F) 
 Rf;fpdhy;> nrhpahik> khh;nghpr;ry;> GspNag;gk;> GspNag;gk;> ntg;gk;> 
fPo;tha; Neha;> ePNuw;wk;> Fd;kk;> tapw;Wg;gprk;> KfNeha;> Fiytyp> ghz;L> 
tapw;Wf; Fj;jy;> IaRuk; Nghk;. 
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thjg;gpzptap W}jw; nrtptha; 
  typjiy typFiy typapU tpopePh; 
 rPjj; njhLthp Ngjpg; gyNuh 
  rpfkyp Kfkf Kfkpb fgkhh; 
 rPjr; Ruk;tphp Ngjr; RuNeha; 
  njwpgLnkd nkhop Fth;Gtp jdpNy 
 <Jf; FjTkp jPJf; Fjth 
  njDk;tpjp apiyet RWFz KdNt 
        (Nj.F) 
6.Tamil name  - re;jdk; 
Botanical name - Santalum album 
English name  - Sandalwood 
Family  - Santalaceae 
Parts used     - Wood 
Action      - Alterative, Stimulant, Cooling, Disinfectant 
Rit -  ifg;G> rpWJth;g;G Æ jd;ik - jpl;gk;> ntg;gk; Æ gphpT - ,dpg;G  
nghJFzk;  
 Nfhjpy; re;jdQ; rPNjh~;zq; nfhz;bUf;Fk;  
 thjgpj;jk; Iak; kdg;gpuik - XJRuk; 
 Nkfk; jdpj;jhfk; ntg;G nrhwp Ak;Nghf;Fk; 
 Mfe; jdf;FWjp ahk;.                   (m.F) 
 ,jdhy; Kf;Fw;wk;> kdf;fyf;fk;> cl;#L> Nghk;> cly; td;ik ngUk 
7.Tamil name  -    Njtjhuk; 
English name  -   Himalayan Cedar 
Botanical name  -  Cedrus deodara 
Family  -  Pinaceae 
Parts Used  -  Wood 
Action   - Astrigent, Febrifuge 
Njtjhuk; Æ Rit - rpWifg;G Æ jd;ik - ntg;gk; Æ gphpT - fhh;g;G  
nghJFzk; 
 Njtjh uf;Fze;jhd; Nrh;e;Jthsh; gPdprj;ijf;  
 fhtfj;jp Nyhl;Lq; fug;gyNt - khtyth; 
 nrhy;Yk;G uhz RunkhLeP Nuw;wj;ij 
 nty;Y kdw;wzpf;F nka;  
       (m.F) 
 ,jdhy; gPdprk;> gioaRuk;> ePNuw;wk;> cly; ntg;gk; ePq;Fk;. NkYk; 
,jid eLf;FthA> Ruk; ,itfSf;Fk; toq;fyhk.; 
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8.Tamil name   - jpg;gpyp 
English name  - Long peper 
Botanical name  - Piper longum 
Family  - Piperaceae 
Parts used  - Fruit 
Action   - Stimulant, Carminative 
Rit - fhh;g;G> jd;ik ntg;gk;> gphpT - fhh;g;G 
nghJFzk;  
 ,Uky; Fd;kk; ,iug;G fag;gpzp 
  <is ghz;L re;ahrk; mNuhrfk; 
 nghUky; Cij rpug;gpzp %h;r;irNeha; 
  G+hpf; FQ;ry Njhlk; gPypfKk; 
 tUk yg;ngUf; NfhL kNfhjuk; 
  thjk; MjpKj; NjhlQ; Ruq;Fspu; 
 ngUkhiyg;Ghp Nkfg; gplfKk;  
  NgUe; jpg;gpypg; Nguq;Fiuf;fNt 
,jdhy; Fd;kk;> Iag;gpzp> ghz;L> Ritapd;ik> nghUky;> Mfpait Nghk 
9.Tamil name  - ,k;G+wy; 
English name  - Dye root 
Botanical name - Oldenlandia unbellata 
Family  - Rubiaceae 
Parts used  - Whole plant 
Action   - Cholagogue,  Styptic 
Rit - ,dpg;G>jd;ik - rPjk;> gphpT - ,dpg;G 
nghJFzk; 
 ,d;Gwh Ntiu,jkha; mUe;jpdh;f;Fg;  
 gpd;Gwh ijabkhL gpj;jKNk - Jd;gk; 
 ,Uky; Rthrk; vhpRuk;t apw;Wg; 
 nghUkYg;gp rk;gwe;J Nghk;. 
,jdhy; clypd; moy;> moy;Ruk;> tapw;wpiur;ry;> tpf;fy; Kjypa Neha;fs; 
Nghk;. 
10.Tamil name - trk;G 
English name  - Sweet-flag 
Botanical name - Acorus calamus 
Family  - Acoraceaea 
Parts used  - Bark 
Action   - Stimulant, Antiperiodic, Germicide, Disinfectant 
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Rit - fhh;g;G> jd;ik - ntg;gk;> gphpT - fhh;g;G  
nghJFzk; 
 ghk;ghjp eQ;rw; Gjg;Gz; typtplghfq; Fd;kk; 
 #k;gh hpuj;jbj; jk;Kf ehw;wk;td; #iyrd;dp 
 tPk;ghk;ig fhrk; gPyPfQ; rypgjk; tPwpUky; 
 jhk;ghq; fpUkp gpitNaF khrpt rk;gpidNa 
 ,jdhy; Itiftyp> Fd;kk;> ,uj;jgpj;jk;> #iy> Kg;gpzp> <uy; 
Neha;fs;> ahidf;fhy; Mfpait Nghk;.  
11.Tamil name - fUQ;rPufk; 
English name  - Black cumin 
Botanical name - Nigella sativa 
Family  - Ranunculaceae 
Parts used  - Seed 
Action      - Emollient, Carminative 
Rit - ifg;G> jd;ik - ntg;gk;> gphpT - fhh;g;G  
nghJf;Fzk;  
 fUQ;rP ufj;jhd; fug;gndhL Gz;Zk; 
 tUQ;rPuha;g; gPerK khw;Wk; - mUe;jpdhy; 
 fha;r;ry; jiytypAq; fz;typAk; NghKyfpy; 
 tha;rr kUe;njdNt it 
,jdhy; cl;#L> ,itfSk;> tapw;Wg; nghUky;> Fd;kk;> khh;Gtyp> tPf;fk;> fhkhiy 
Mfpait ePq;Fk;. 
12.Tamil name - kUNjhd;wp 
English name  - Henna plant 
Botanical name  - Lawsonia innermis 
Family  - Lythraceae 
Parts used  - Root 
Action   - Astrigent 
Rit - Jth;;g;G> jd;ik - ntg;gk;> gphpT - fhh;g;G  
nghJFzk;: 
 fPy; thA> Filr;ry;> jiyNeha;> iffhy; typ> vhpr;ry;>  
',J thjklf;fpahfTk; thjj;ijj; jPh;f;fTk; rpwe;j gaDs;s kUe;jhf ,Uf;fpwJ 
vd;W mDgt G+h;tkhf n`hd;dp ngh;f;fh;. 
13. Tamil name - ,e;Jg;G 
English name  - Rock Salt 
Action   - Laxative , Anti inflammatory 
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nghJFzk;: 
 'ml;lFd;k ke;jk; mrph;f;fuQ;#h; rPjgpj;jk; 
 Jl;litak; ehbg;Gz; Nghlq;fs; - nfl;lkyf; 
 fl;Ltpl tpe;ijaf; fhkpa Neha; td;fug;ghd; 
 tpl;Ltpl tpe;Jg;ig tps;" 
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INTERNAL MEDICINE - INGREDENTS 
KODIVELI CHOORANAM 
 
 
 
       ngUq;fhak; 
 
 
 
 
kUNjhd;wp Nth; 
Rf;F Nfh\;lk; 
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           Xkk; 
 
 
 
 
 
 
 
nfhbNtyp 
trk;G re;jdk; 
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fUQ;rPufk; Njtjhuk; 
jpg;gpyp ,k;G+uy; 
,e;Jg;G 
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EXTERNAL MEDICINE: 
Tamil name  - jpUf;fs;sp 
English name  - Milk Hedge plant 
Botanical name - Euphorbia tirucalli 
Family  - Euphorbiacea 
nghJFzk; 
 thj Klf;fYk; td;fpue;jp Fl;lk; NghQ; 
 rPjnkhop Aq;fpUkp NrUNkh? - khnj! 
 gUFgf;f NehAlNd gho;q;fug;ghd; ePUe; 
 jpUFf;fs;spg; ghyhw; nwsp 
 ,jdhy;> tspKlf;Ffs;> ngUNeha;> IaNeha;> gf;f#iy mit Nghk;. 
2.Tamil name: vembu ennai 
Botanical name  :  azadirachta indica 
Family  : Meliaceae 
Parts used  : seed 
Suvai   : kaippu 
Thanmai  : veppam 
Pirivu   : karppu 
Chemical constituents: 
 Nimbidiol,margocinin, margocilin, nimbilin,nimolinin,nimbolide. 
Action  
 Stimulant 
 Antiseptic 
 insecticide 
Uses 
Anti vatha disease, scabies, eczema,fever cured 
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EXTERNAL MEDICINE – INGREDENTS 
THIRUGUKALLI ENNAI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
jpUFf;fs;sp 
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nfhbNtyp #uzk; 
 
jpUFf;fs;sp vz;nza; 
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EXTERNAL THERAPY: 
1.Tamil name  - G+z;L 
Boanical name - Allium sativum 
Family  - liliaceae 
Part used   - bulb 
English name  - Garlic 
nghJFzk; 
 rd;dpnahU thje; jiyNehT jhs; typ 
 kd;dptU ePh;f;Nfhit td;rPjk; - md;dNk! 
 cs;Ss;sp fz;gha; tis%y NuhfKk; Nghk; 
 nts;Ss;sp jd;dhy; ntUz;L 
 ,ij Kg;gpzp tspNeha;fs;> ePNuw;wk; ,itfl;L nfhLf;fyhk;. 
2.Tamil name  - kpsF 
English name  - Peper 
Botanical name  - Piper nigram 
Family  - Piperaceae 
Parts used  - Fruit 
Action   - Rubefacient, Stimulant to skin, Resolvent 
Suvai   - kaippu,karppu 
Thanmai  - veppam 
Pirivu   - karppu 
nghJFzk; 
 msitAwhf;fhuk; mile;jpUf;Fk; thj 
 tpisitnay; yhkWf;Fk; nka;Na - kpsfpd;fha; 
 fz;lth;f;Fk; ,d;gkhk; fhhpifNa! rpo;%yq; 
 nfhz;lth;f;F ed; kUe;jhq; $W 
 ,J tspNeha;fisAk; rPo;%yj;ijAk; ePf;Fk; 
3.KUq;if ,iy 
nghJFzk; 
 nrwpke;jk; ntg;ge; njwpf;Fe; jiyNeha; 
 ntwp%h;r;ir fz;Nzha; tpyFk; - kwNk 
 neUq;ifapiy nahj;jtpop NehpioNa! ey;y 
 KUq;if apiyia nkhop 
4.Tamil name  - ngUq;fhak; 
English name  – Asafoetida 
Botanical name - Ferula asafoetida 
Fmaily  - Apiaceae 
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Parts used   - Resin 
Rit - ifg;G> fufug;G / jd;ik - ntg;gk; gphpT - fhh;g;G 
nghJFzk;: 
 je;jNt je;j %yj;njOk;gpzp 
  rUtfhsk; tpUr;rpfq;fPlk;kh 
 ke;jk;thjk; cjhth;j;jk; my;Fy;Neha; 
  khh;gzq;fl;l Fd;kk;kNfhjuk; 
 ce;Jnfh;g;ge;jpd tpj;jpuQ;R+iyr;R+h; 
  cjpug;G+r;rp rpNyj;Jkj;JWk;typ 
 te;jnka;f;fLg; NghbitKw;WNk 
  khAehWew; fhaq;fpilf;fpNd           (Nj.F) 
,jdhy; ke;jk;> Vg;gk;> thjk;> #jfthA> Fd;kk;> ngUtapW> #jfr;R+iy> 
FUjpapYs;s Ez;GO> Iaj;jhy; gpwe;j typfs; cly; fLg;G> vd;Dk;k ,itfs;. 
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EXTERNAL THERAPY - INGREDENTS 
MURUGAI  SURASA  OTTRADAM 
 
 
 
 KUq;if ,iy 
 
 
kpsF G+z;L 
 Njq;fha; jpUty; 
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ANNEXURE II 
BIO – CHEMICAL ANALYSIS 
BIO – CHEMICAL ANALYSIS OF KODIVELI CHOORANAM 
Preparation of the extract: 
5gms of  the drug was weighed accurately and placed in a 250ml clean beaker then 50ml 
distilled water is  added and dissolved well. Then it is boiled well for about 10 minutes. It 
is cooled and filtered in a 100ml volumetric flask and then it is  made  to 100ml with 
distilled water. This fluid is taken for analysis. 
QUALITATIVE ANALYSIS 
S.NO       EXPERIMENT    OBSERVATION INFERENCE 
1. 
 
Test for calcium: 
2ml of the above prepared extract is 
taken in a clean test tube. To this add 
2 ml of 4%ammonium oxalate 
solution. 
A white precipitate 
is formed. 
 
Indicates the 
presence of 
calcium. 
 
2. 
 
Test for sulphate: 
2ml of the extract is added to 
5%bariumchloride solution. 
A  white precipitate 
is 
formed 
 
Indicates the 
presence  of 
sulphate. 
 
3. 
 
Test for chloride: 
The extract is treated with silver 
nitrate solution 
No  white 
Precipitate is 
formed. 
 
Absence of 
Chloride 
 
4. 
 
Test for carbonate: 
The substance is treated with 
concentrated Hcl. 
No brisk 
effervescence is 
formed 
Absence of 
carbonate. 
 
5. 
 
Test for Starch: 
The extract is added with weak iodine 
solution. 
Blue colour is 
formed 
 
Indicates the 
Presence of 
starch. 
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6. 
 
Test for Ferric Iron: 
The extract is treated with 
concentrated glacial acetic acid and 
potassium ferro cyanide. 
No blue colour is 
formed. 
 
Absence of 
ferric iron. 
7. 
 
Test of Ferrous Iron: 
The extract is treated with 
concentrated Nitric acid and 
ammonium thiocyanide solution. 
No blood red 
Colour is formed. 
 
Absence of 
ferrous iron. 
8. 
 
Test for phosphate: 
The extract is treated with ammonium 
molybdate and concentrated nitric 
acid. 
No yellow 
Precipitate is 
formed. 
 
Absence of 
phosphate 
9. 
Test for albumin: 
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate 
formed. 
 
Absence of 
albumin. 
 
10. 
 
Test for Tannic acid: 
The extract is treated with ferric 
chloride. 
Blue black 
precipitate is 
formed. 
 
Indicates the 
presence of 
Tannic acid. 
 
11. 
 
Test for unsaturation: 
Potassium permanganate solution is 
added to the extract. 
It gets decolorised. 
 
Indicates the 
Presence of 
unsaturated 
compound. 
 
12. 
 
Test for the reducing sugar: 
5ml of Benedict’s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 minutes and added 8-10 
drops of the extract and again boil it 
No colour change 
occurs. 
 
Absence  of 
reducing 
sugar. 
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for 2 minutes. 
 
13. 
Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried well. 
After drying,1% ninhydrin is sprayed 
over the same and dried it well. 
Violet Colour is 
formed 
 
Indicates the 
presence of 
amino acid. 
 
14. 
Test for zinc: 
The extract is treated with Potassium 
ferro cyanide. 
No white Precipitate 
is formed 
 
Absence of zinc. 
 
 
 Inference: 
  The given sample of “KODIVELI  CHOORANAM” contains calcium, Sulphate, 
Starch, tannic acid,  unsaturated compound, and amino acid. 
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                                                   ANNEXURE III 
                   FOURIER  TRANSFORM  INFRARED  SPECTROSCOPY  
 
AIM 
            To evaluate the FTIR characterization of  Kodiveli chooranam 
PROCEDURE   
            Fourier transform infrared spectroscopy it is n important and more advanced 
technique. It is used to identify the functional group to determine the quality and 
consistency of the sample material and can determine the amount of compound present in 
the sample. 
            The FTIR- Infrared is passed from a source through a sample. This infrared is 
absorbed by the sample according to the chemical properties and some are transmitted. 
The spectrum that appears denotes the molecular absorption and transmission. It forms 
the molecular finger print of the sample. It is recorded as wavelength and the peaks seen 
in the spectrum indicate the amount of material present. 
 
RESULT 
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Table 1.2 
FTIR data interpretation of  Kodiveli chooranam 
 
Wave number Vibrational modes of 
Kodiveli chooranam 
Functional groups 
2933.73 N-H Stretching Amine salt 
1707.00 C=O Stretching Conjugated aldehyde 
1645.28 N-H Bending Amine 
1514.12 N-O Stretching Nitro compound 
1423.47 C-H Bending Alkane 
1330.88 S=O Stretching Sulfone 
1246.62 C-N Stretching Amine 
1155.36 S=O Stretching Sulfone 
1035.77 S=O Stretching Sulfoxide 
864.77 - Unknown 
524.64 C-L Stretching Halo compound 
 
INFERENCE 
    FTIR spectra analysis indicates the presence of some organic functional groups such as 
Halo compound, Sulfoxide, Sulfone, Amine, Fluro coumpound, Alkane, Nitro compound, 
Conjugated aldehyde, Aromatic coumpound, Amine salt and carboxylic cid. The 
presence of Sulfoxide, Sulfone, Amine, Sulfonamide are indicates that contains anti-
inflammatory, analgesic, antibiotics, antisaeptic activities. 
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                                                     ANNEXURE IV 
                                              I ANTI-INFLAMMATORY 
ANTI-INFLAMMATORY ACTIVITYOF KODIVELI CHOORANAM 
             The anti-inflammatory activities of KODIVELI CHOORANAM at 100 mg/kg 
& 200 mg/kg doses were evaluated using carrageenan-induced paw edema method. The 
inflammation was readily produced in the form of edema with the help of irritant such as 
carrageenan. Carrageenan is a sulphated polysaccharide obtained from sea weed 
(Rhodophyceae) and when injected cause the release of prostaglandins by the way it 
produces inflammation and edema. 
REQUIREMENTS: 
Animal                                : Albino rat (180-200 g) 
Drugs and chemicals          : Carrageenan (1%w/v), Diclofenac sodium (standard), 
Carboxy methyl cellulose (1%w/v), 
 Plethysmo meter. 
Test compounds                : KODIVELI CHOORANAM    
METHOD: 
Anti-inflammatory activity was performed by the following procedure of Bhandri et al(1)
 
The animals were divided into 4 groups each having six animals. A freshly prepared 
suspension of carrageenan (1% w/v , 0.1 ml) was injected to the planter region of left 
hind paw of each rat. One group was kept as control and the animals of the other groups 
were pretreated with the KODIVELI CHOORANAM test Compounds dissolved with 2 
ml sterile water given through orally and diclofenac 10mg/kg (ip) 30 min before the 
carrageenan treatment. The paw volumes of the test compounds, standard and control 
groups were measured at 60,240,360 minutes of carrageenan treatment with the help of  
plethysmometer . Mean increase in paw volume was measured and the percentage of 
inhibition was calculated. 
 
118 
 
 
% Anti-inflammatory activity = (Vc-Vt / Vc) x 100 
Where, Vt-mean increase in paw volume in rats treated with test compounds, 
Vc-mean increase in paw volume in control group of rats. 
TABLE No.1 
ANTI-INFLAMMATORY ACTIVITY OF KODIVELI CHOORANAM 
Treatment Dose (mg/kg) 
Paw volume(ml) 
as measured by 
mercury 
displacement at 6 
hour 
Percentage 
inhibition of paw 
edema 
Group I 
Normal saline 
10ml/kg orally 4.70±0.96 - 
Group II 
Std 
10mg/kg 
I.P.Diclofenac 
sodium 
1.20±0.40 74.46%*a 
Group III 
KODIVELI 
CHOORANAM 
100mg/kg.Orally. 1.56±0.48 66.80%*a 
Group IV 
KODIVELI 
CHOORANAM 
200mg/kg.Orally. 1.40±0.52 70. 21%*a 
* Data are expressed as Mean ± S.E.M. 
*Data were analyzed by one way ANOVA followed by Newman’s keul’s multiple range 
tests, to determine the significance of the difference between the control group and rats 
treated with the test compounds. 
*a   Values were significantly different from normal control at P< 0.01. 
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62
64
66
68
70
72
74
76
Percentage inhibition of Paw edema
Group II
Group III
Group IV
 
RESULTS 
Anti- inflammatory activity 
 KODIVELI CHOORANAM at doses 100mg/kg & 200mg/kg were tested for their 
Anti- inflammatory activity by using carrageenan Induced rat paw edema method and the 
results are tabulated in table no 1.  The results reveals that  KODIVELI CHOORANAM 
at 100mg/kg & 200mg/kg doses possesses significant Anti- inflammatory activity when 
compared to control group at p<0.01. 
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ANNEXURE IV 
1I. ANALGESIC ACTIVITY 
ANALGESIC ACTIVITY OF KODIVELI CHOORANAM 
Hot plate method 
Animals  
 Young wister albino rats of either sex aged 4-5 weeks, average weight 100-
150 gm were used for the experiment. The rat were purchased from the animal 
TANVASA. They were kept in standard environmental condition (at 24.0±0°C 
temperature and    55-65% relative humidity and 12 hour light/12 hour dark cycle) for 
one week for acclimation after their purchase and fed ICDDRB formulated rodent 
food and water ad libitum. The set of rules followed for animal experiment were 
approved by the institutional animal ethical committee. (Zimmerman,1893). 
 
 Experimental animals of either sex were randomly selected and divided into 
four groups designated as group-I, group-II, group-III and group-IV consisting of five 
Rats in each group for control, positive control and test sample group respectively. 
Each group received a particular treatment i.e. control (1% Tween-80 solution in 
water, 10ml/kg, p.o.), positive control (Diclofenac sodium 10 mg/kg, p.o.) and the test 
sample (drug of 100mg/kg , p.o. & 200mg/kg, p.o. respectively). The animals were 
positioned on Eddy’s hot plate kept at a temperature of 55±0.5 0C. A cut off period of 
15 s (Franzotti et al., 2000) was observed to avoid damage to the paw. Reaction time 
was recorded when animals licked their fore or hind paws, or jumped prior to and 0, 
30, 60 and 90 min after oral administration of the samples (Eddy et al., 1953; 
Kulkarni, 1999; Toma et al., 2003). 
 
Statistical analysis  
 The results of statistical analysis for animal experiment were expressed as 
mean ± SEM and were evaluated by ANOVA followed by Dunnet’s multiple 
comparisons. The results obtained were compared with the vehicle control group. The 
p<0.05, 0.001 were considered to be statistically significant. 
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TABLE NO.1 
 
GROUP 
 
DOSE 
Mean latency before and  after    
administration 
% inhibition 
0Min 30Min 60Min 90Min 30 
Min 
60 
Min 
90 
Min 
Group I Vehicle 1.76± 
0.220 
1.95± 
0.226 
1.66± 
0.198 
2.08± 
0.267 
- - - 
Group II 
Diclofenac 
10 1.84± 
0.088 
5.12± 
0.625 
7.47± 
0.645 
11.17± 
1.008 
61.91 77.77 81.37 
Group III 
Kodiveli 
Chooranam 
100 1.71± 
0.074 
2.77± 
0.265 
4.69± 
0.776 
4.67± 
0.617 
29.60 64.60 55.46 
Group IV 
Kodiveli 
Chooranam 
200 1.57± 
0.018 
3.07± 
0.852 
5.84± 
0.514 
5.43± 
0.465 
36.48 71.57 61.69 
 
0
10
20
30
40
50
60
70
80
90
30 min 60 min 90 min
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Result  
 Results of hotplate test are presented in Table  for drugs respectively. The drug  
were found to exhibit a dose dependent increase in latency time when compared with 
control. At 90 minutes, the percent inhibition of two different doses (100 and 200 
mg/kg body weight) was 55.46%&61.69% respectively. The results were found to be 
statistically significant (p<0.001). 
 
Discussion 
 Siddha is the first system of medicine to emphasize health as the perfect state 
of physical, psychological, social and spiritual components of a human being. The 
fundamental principle of this medicine successfully eliminates the evil side effects 
without losing the beneficial medicinal properties. Diclofenac was used as a reference 
drug in the current study as it has both central, peripheral actions and can significantly 
treat nociceptive pain as in this model.  In the current study, pain threshold increased 
significantly during the period of observation in all the drug treated groups, with 
maximum effect observed in the  Kodiveli chooranam  at a dose of 100mg/kg as 
shown in table 1. The analgesic activity of drug was comparable to diclofenac at 30, 
60,120minutes appears to be a significant finding and suggests that this drug has a 
slow onset of analgesic action 
 
CONCLUSION: 
 KODI VELI CHOORANAM possess significant analgesic and anti-
inflammatory potential as evidenced from the present preclinical study. These 
findings support the use of Kodiveli chooranam  in traditional system of medicine for 
the management of pain and inflammatory conditions. Further studies are needed to 
be carried out in other animal models of pain and inflammatory to validate its efficacy 
and to identify the active phyto constituents in the formulation and their targets in 
pain and inflammatory pathways. 
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TOXICITY STUDIES 
EVALUATION OF ACUTE TOXICITY STUDY OF  
Effect of Acute Toxicity Study (14 Days) of KODIVELI CHOORANAM 
Table no –1   
Physical and behavioral examinations. 
Group 
no. 
Dose(mg/kg) Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
 
Table no-2 
 Home cage activity 
  
Functional 
and 
Behavioural 
observation 
Observation 
5mg/kg 
Group 
(G-I) 
50mg/kg 
(G-II) 
300mg/kg 
(G-III) 
 
1000mg/kg 
(G-IV) 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body 
position 
Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Tonic 
involuntary 
Movement 
Normal 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 
Approach 
response 
Normal 3 3 3 3 3 
Touch 
response 
Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response 
Normal 3 3 3 3 3 
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Table no-3 
Hand  held  observation 
Functional 
and 
Behavioral 
observation 
Observa
tion 
Cont
rol 
5 mg/ 
kg 
(G-I) 
50 
mg/kg 
(G-II) 
300mg
/kg 
(G-III) 
1000mg
/kg 
(G-IV) 
2000m
g/kg 
(G-V) 
Fem
ale 
n=3 
Female 
n=3 
Female 
n=3 
Femal
e n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 3 
Pupillary 
reflex 
Normal 3 3 3 3 3 3 
Abdominal 
tone 
Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
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Table no-4 
 Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
RESULT: 
 From acute toxicity study it was observed that the administration of 
KODIVELI CHOORANAMat a dose of 2000 mg/kg to the rats do not produce 
drug-related toxicity and mortality. So No-Observed-Adverse-Effect- Level 
(NOAEL) of KODIVELI CHOORANAM is 2000 mg/kg. 
 
DISCUSSION 
 KODIVELI CHOORANAMwas administered single time at the dose of 
5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot 
study and literature review. All animals were observed daily once for any abnormal 
clinical signs. Weekly body weight and food consumption were recorded. No 
mortality was observed during the entire period of the study. Data obtained in this 
study indicated no significance physical and behavioral signs of any toxicity due to 
administration of KODIVELI CHOORANAMat the doses of 5mg/kg,50mg/kg , 
300mg/kg, 1000mg/kg and 2000mg/kg to rats.  
 
 At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand 
held activity were observed. Home cage activities like Body position, Respiration, 
Clonic involuntary movement, Tonic involuntary movement, Palpebral closure, 
Approach response, Touch response, Pinna reflex, Sound responses, Tail pinch 
response were observed. Handheld activities like Reactivity, Handling, Palpebral 
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closure, Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominaltone, 
Limb tone were observed. Functional and behavioral examination was normal in all 
treated groups.Food consumption of all treated animals was found normal as 
compared to normalgroup. 
 
 Body weight at weekly interval was measured to find out the effect of 
KODIVELI CHOORANAMon the growth rate. Body weight change in drug 
treated animals was found normal. 
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SUB-ACUTE TOXICITY STUDY IN WISTAR RATS TO EVALUATE 
TOXICITY PROFILE OF KODIVELI CHOORANAM 
Table :1 
EFFECT OF SUB- ACUTE DOSE (28 DAYS)OF KODIVELI 
CHOORANAMONBODY WEIGHT IN GRAM 
 
GROUP CONTROL LOW MID HIGH 
1
st
 day 124.3±1.03 127±1.543 126.3±2.231 128.3±2.23 
7
th
 day 134.3±1.03 133.3±1.343 133±2.113 139±2.11 
14
th
 day 136.1±1.004 104.3±1.12 104.4±2.012 105.4±2.012 
21
st
 day 105.3±2.120 112.2±1.501 106±1.131 107±1.13 
28
th
 day 115.3±1.041 114.3±1.202 145±2.0405 148±2.040 
 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one 
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group. 
 
 
EFFECT OF SUBACUTE DOSE (28 DAYS)OF KODIVELI CHOORANAM 
Table : 2 
KODIVELI CHOORANAMON ORGAN WEIGHT (PHYSICAL 
PARAMETER) IN GRAM 
 
GROUP CONTROL LOW MID HIGH 
HEART 0.63±0.02 0.44±0.04 0.51±0.11 0.61±0.02 
LIVER 2.51± 0.23 2.53±0.23 2.40±0.01 2.43± 0.23 
LUNGS 1.51±0.10 0.51±0.14 0.70±0.24 1.63±0.10 
KIDNEY L 0.63±0.02 1.72±0.03 0.63±0.02 0.61±0.02 
 R 0.61±0.024 1.34±0.02 0.61±0.024 0.62±0.024 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one 
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Table no: 3 
EFFECT OF SUB- ACUTE DOSE (28 DAYS)OFKODIVELI 
CHOORANAMONHAEMATOLOGICAL PARAMETERS 
 
Drug 
treatm
ent 
RBC 
millio
n 
cells/c
mm 
WBC  
cells/cmm 
Haemoglob
ingm % 
Differential count % 
    
Neutop
hils 
Eosinop
hils 
Monoc
yte 
Limpo
cyte 
Contro
l 
5.41±0
.40 
6272.41±2
3.32 
12.60±0.45 
43.27±
1.20 
3.73±0.
11 
0.65±0
.15 
25.13±
3.32 
LOW 
5.67±0
.20 
66354.04±
23.22 
12.20±0.43 
47.54±
1.41 
2.30±0.
14 
0.32±0
.30 
25.22±
3.51 
MID 
5.53±0
.21 
6324.25±3
2.35 
12.11±1.03 
42.32±
2.22 
3.64±0.
12 
0.52±0
.40 
25.13±
3.32 
HIGH 
5.36±0
.21 
6498.25±3
2.35 
12.11±1.03 
40.32±
2.22 
3.70±0.
12 
0.54±0
.40 
26.13±
3.32 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one 
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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EFFECT OF SUB- ACUTE DOSE(28 DAYS)OF 
KODIVELICHOORANAMON BIOCHEMICAL PARAMETERS 
Table No: 4 
Drug 
Treatment 
SGPT 
(IU/L) 
SGOT 
(IU/L) 
ALT 
(IU/L) 
Urea 
(mg/dl) 
Creatinine 
(mg/dl) 
Control 34.14±3.02 44.24±4.31 243.12±11.32 57.35±3.00 0.74±0.03 
LOW 34.13±3.22 43.23±4.01 25.11±12.42 52.53±2.42 0.70±0.04 
MID 32.21±4.44 46.31±2.21 24.45±4.14 51.12±2.22 0.65±0.04 
HIGH 34.21±4.44 42.31±2.21 23.45±4.14 52.12±2.22 0.66±0.04 
 
 
 
 
EFFECT OF SUB- ACUTE DOSE (28 DAYS) OFKODIVELI 
CHOORANAMBIOCHEMICAL PARAMETERS 
Table no: 5 
GROUP CONTROL 
KODIVELI 
CHOORANAM 
(200mg/kg) 
KODIVELI 
CHOORANAM 
(400mg/kg) 
KODIVELI 
CHOORANAM 
(600mg/kg) 
TOTAL 
BILIRUBIN 
(mg/dl) 
0.5±0.27 0.45±0.827 0.8198±0.3376 0.99±0.199 
  
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Table no: 6 
EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF ERANDAMOOLA 
CHOORANAMON FOOD INTAKE IN GRAM 
GROUP CONTROL L M H 
1
st 
DAY 21.33±13.6110 22.1672±15.3 15.10±22.71 20.5±8.62 
7
th 
DAY 18.5±12. 13.863±13.67 19.73±10.853 14.17±15.41 
14
th 
DAY 21.83±8.72 13.83±15.28 13±14.96 22.72±9.981 
21
st DAY
 14.87±13.4 18±8.466 18.88±10.43 22.17±9.02 
28
th
 DAY 15.10±11.38 21.38±11.50 13±8.90 13±7.57 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group 
 
Table no: 7 
Effect of Sub- Acute Dose (28 Days) Of KODIVELI CHOORANAM 
On Water Intake in ml 
GROUP CONTROL 
KODIVELI 
CHOORANAM 
(200mg/kg) 
KODIVELI 
CHOORANAM 
(400mg/kg) 
KODIVELI 
CHOORANAM 
(600mg/kg) 
1
st 
DAY 98.38±13.50 89.12±14.426 102.10±21.99 67.5±7.03 
7
th 
DAY 85.5±11.78 100.863±12.70 76.73±9.863 81.7±14.50 
14
th 
DAY 58.83±8.72817 90.63±14.812 80±13.92 89.12±8.981 
21
st 
DAY 91.687±12.49 85±8.462 65.88±9.450 89.1717±8.792 
28
th
 DAY 82.10±11.40 88.38±11.54 80±8.961 70±7.53 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group 
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Table no:8 
EFFECT OF SUB ACUTE DOSES (28 DAY) OF KODIVELI 
CHOORANAMONELECTROLYTES: - 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-
way ANOVA followed by Dennett’s(n=6); NS- non-significant, *p<0.05, 
**p<0.01, ***p<0.001,  
 
RESULTS: 
CLINICAL SIGNS: 
 All animals in this study were free of toxic clinical signs throughout the 
dosing   period of 28 days. 
Mortality: 
 All animals in control and in all the treated dose groups survived throughout 
the dosing period of 28 days. 
Body weight: 
 Results of body weight determination of animals from control and different 
dose groups exhibited comparable body weight gain throughout the dosing period 
of 28 days. 
Food consumption: 
 During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable with 
that by control animals. 
 
GROUP CONTROL 
KODIVELI 
CHOORANAM 
(200mg/kg) 
KODIVELI 
CHOORANAM 
(400mg/kg) 
KODIVELI 
CHOORANAM 
(600mg/kg) 
Sodium (mg/dl) 145.10±0.55 149.30±0.92 151±0.7571 141.80±0.70 
Calcium(mg/dl) 10.580±0.139 9.20±0.783*** 7.7±0.199*** 8.180±0.1* 
Phosphorus 
(Mg/dl) 
4.278±0.17 5.3010±0.15
ns 
6.35630±1
s 
6.037±0.02* 
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Organ Weight: 
 Group Mean Relative Organ Weights (% of body weight) are recorded in 
Table No.22 Comparison of organ weights of treated animals with respective 
control animals on day 29 was found to be comparable similarly. 
Hematological investigations: 
 The results of hematological investigations conducted on day 29 revealed 
following significant changes in the values of different parameters investigated 
when compared with those of respective controls; however, the increase or 
decrease in the values obtained was within normal biological and laboratory limits 
or the effect was not dose dependent. 
Biochemical Investigations: 
 Results of Biochemical investigations conducted on the day 29th and 
recorded in Table no 24, 25 revealed the following significant changes in the values 
of hepatic serum enzymes studied. When compared with those of respective 
control. However, the increase or decrease in the values obtained was within 
normal biological and laboratory limits. 
INTERPRETATION: 
1)  All the animals from control and all the treated dose groups up to 15ml/kg 
 survived throughout the dosing period of 28 days. 
2)   No signs of toxicity were observed in animals from different dose groups 
 during the dosing period of 28 days. 
3)   Animals from all the treated dose groups exhibited comparable body weight 
 gain with that of controls throughout the dosing period of 28 days. 
4)  Food consumption of control and treated animals was found to be 
 comparable throughout the dosing period of 28 days 
5)    Haematological analysis conducted at the end of the dosing period on day 
 29th, revealed no abnormalities attributable to the treatment. 
6)  Biochemical analysis conducted at the end of the dosing period on day 29
th
, 
 no abnormalities attributable to the treatment. 
7)  Organ weight data of animals sacrificed at the end of the dosing period was 
 found to be comparable with that of respective controls. 
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ANNEXURE – V 
ASSESMENT FORMS 
 
  FORM I : Screening form 
            FORM II : Consent form 
            FORM III : History Proforma on enrollment 
  FORM IV :  Clinical Assessment on enrollment and on visit 
   FORM V :  Laboratory Investigation form 
            FORM VI :  Drug compliance Form 
            FORM VII : Adverse drug reaction Form  
            FORM VIII  : Withdrawal form 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE THE 
THERAPEUTIC EFFICACYOF KODIVELI CHOORANAM[INTERNAL] AND 
THIRUGUKALLI YENNAI [EXTERNAL] WITH OTRADAM [EXTERNAL 
THERAPY] IN SANTHUVATHAM [POLYARTHRITIES]. 
FORM-I 
(SCREENING AND SELECTION PROFORMA) 
1. OPD/IPD No.       2. Date:   3. SI. No.  .                       
   
4.Name___________ 5.Age: _____   6. Gender:________  7.Phone no:_________ 
INCLUSION CRITERIA: 
 Age   :  between 20- 70 years  
 Sex  : Both male and female 
 Joints pain : more than 5 joints 
 Swelling   
 Stiffness  
 Restricted movements in affected joint.  
 Willing for admission and study in IPD for 30-40 days or willing to attend OPD 
 
EXCLUSION CRITERIA: 
 Rheumatoid arthritis 
 Other systemic illness 
 Gout  
 Malignancy  
 Pregnancy women and Lactating mother  
 Tuberculosis  
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WITHDRAWAL CRITERIA: 
1. Intolerance to the drug and development of adverse reactions during drug 
trial. 
2. Poor patient compliance and defaulters. 
3. Patient turned unwilling to continue in the course of clinical study. 
4. Occurrence of any serious illness during the course of study. 
 
DATE  :  
STATION :     Signature of the Investigator 
 
 
 
      SIGNATURE OF THE GUIDE / HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF  SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE THE 
THERAPEUTIC EFFICACY OF KODIVELI CHOORANAM[INTERNAL] AND  
THIRUGUKALLI YENNAI [EXTERNAL] WITH OTRADAM [EXTERNAL 
THERAPY] IN SANTHUVATHAM [POLYARTHRITIES]. 
FORM-II  
CONSENT FORM 
Certificate by Investigator 
 I certify that I have disclosed all details about the study in the terms  
readily understood by the patient. 
Date: ……………..     Signature of the  
Signature of the Investigator: ……………                Guide/HOD: ………………………. 
Name: ……………..                           Name: …………………………….. 
Consent by Patient 
 I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
 I am aware of my right to withdraw from the trial at any time during the course of the 
trial without having to give the reasons for doing so. 
 I, exercising my free power of choice, hereby give my consent to be included as a 
clinical trial of KODIVELI CHOORANAM[INTERNAL] AND  THIRUGUKALLI 
YENNAI [EXTERNAL] WITH OTRADAM [EXTERNAL THERAPY] IN 
SANTHUVATHAM [POLYARTHRITIES].      
 
Date: ………………..   Signature: ………………………………… 
Name: ……………………………………. 
Date: ……………….    Signature of Witness: ……………………. 
Name………….. …………………………   
  Relationship: …………………………….   
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murpdH rpj;j kUj;Jtf; fy;Yhhp kw;Wk; kUj;Jtkid 
ghisaq;Nfhl;il 
gl;lNkw;gbg;G rpwg;G kUj;Jtj;Jiw 
 
‘nfhbNtyp#uzk;”kw;Wk; ‘jpUFfs;sp vz;nza;” ,tw;wpd; ghpfhpg;Gj; jpwidf; 
fz;lwpAk; kUj;Jt Ma;Txg;Gjy; gbtk; Ma;thsuhy; rhd;wspf;fg;gl;lJ. 
 
ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GhpAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp  :       ifnahg;gk;: 
,lk; :        ngaH: 
Nehahspapd; xg;Gjy; 
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik kw;Wk; 
kUj;Jt topKiwiag; gw;wpAk; njhlHe;J vdJ cly; ,af;fj;ij 
fz;fhzpf;fTk;> mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf; $l 
ghpNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; 
$wg;gl;lJ. 
 ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; chpikia 
njhpe;jpUf;fpd;Nwd;. 
 ehd; vd;Dila Rje;jpukhfj; NjHT nra;Ak; chpikiaf; nfhz;L 
re;Jthjk; vd;Dk; Neha;f;fhd nfhbNtyp#uzk; kw;Wk; jpUFfs;sp vz;nza;; 
Mfpatw;wpd; ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;F vd;id cl;gLj;j 
xg;Gjy; mspf;fpNwd;. 
 
Njjp :       ifnahg;gk;: 
,lk; :          ngaH :  
     
       rhl;rpf;fhuHifnahg;gk;: 
       ngaH : 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU  MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE THE 
THERAPEUTIC EFFICACYOF KODIVELI CHOORANAM [INTERNAL] AND 
THIRUGUKALLI YENNAI [EXTERNAL] WITH OTRADAM [EXTERNAL] IN 
SANTHUVATHAM [POLYARTHRITIES]. 
FORM III 
 
HISTORY PROFORMA ON ENROLLMENT 
 
1. Serial No of the case:   _______________                           2. OPD/IPD No:________ 
 
3.Name: ____________                                                          4. Gender:  
 
5. Age (years): _________   DOB    
      
 Date       Month            Year 
 
6. Address: -------------------------------------- 
 -------------------------------------- 
 -------------------------------------- 
 
7. A. Occupation:    -----------------------------                         B. Income ----------------- 
8. Educational Status:   A) Illiterate                  B)Literate  
 
 
9. Height: ---------- cm                10.Weight:----------kg 
 
11. Complaints and Duration: 
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12. Past History                     
 Hypertension    ______________      
 Diabetes mellitus ______________      
 Asthma  ______________      
 PT   ______________ 
Other   ______________ 
 
13. HABITS 
 
A) Smoking : 1. Yes                 duration ________ years;    Number - _____     2. No  
 
B) Alcoholism:1. Yes                duration ________ years;    Quantity- ____ ml 2. No  
 
C) Tobacco chewing:  1. Yes                duration ________ years                          2.No 
 
D) Betel chewing     :  1. Yes                duration ________ years                          2.No 
 
14. Dietary style:   A.Pure vegetarian                B.Non-vegetarian                C. Mixed diet 
 
15. Drug history: Had the patient been treated before with allopathy drug?  
 
                                A) Yes                                    2) No                                     
 
16 Marital status :1.Married         2.Unmarried                                                  
 
17. Family history : 
Whether this problem runs in family?             1. Yes                               2.No   
 
(If yes, mention the relationship) 
 18. Bowel habits & micturition:      Normal                                      Abnormal 
(Details of an abnormality) 
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19. Psychological state:      Normal                    Anxiety                   Depression            
 
 
 
Signature of the Investigator                          Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE THE 
THERAPEUTIC EFFICACYOF KODIVELLI CHOORANAM [INTERNAL] AND  
THIRUGUKALLI YENNAI [EXTERNAL] WITH OTRADAM  
[EXTERNAL THERAPY] IN SANTHUVATHAM [POLYARTHRITIES]. 
FORM IV 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
1. S.No:  _______                                                 
2. OPD/IPD No: __________                         
3.  Name: _______________________ 
4. Gender      : __________ 
  5. Date of assessment: ________________    
 
SIDDHA SYSTEM OF EXAMINATION 
I. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
Naadi: [pulse perception] 
 Naa:[tongue] 
Niram: [complexion]    
Mozhi: [voice] 
Vizhi: [eyes]  
 Malam: [bowel habits / stools] 
Moothiram: 
Sparisam: [palpatory  perception] 
2. NEER KURI: 
Niram: 
Edai: 
Nurai: 
Enjal:                                                                                                                                                                             
Manam: 
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III. NEI KURI 
 
5. THEGI: [ TYPE OF BODY CONSTITUTION]   
 
6.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
Kurinji                       Mullai                  Marutham                Neithal                      Palai 
(Hilly terrain)           (Forest range)        (Plains)                (Coastal belt)       (Arid regions)  
7. KAALAM: 
Kaarkalam -                      Pinpanikalam  - 
Koothirkalam -                          Ilavenil - 
Munpanikalam -                          Muthuvenil - 
 
8. GUNAM: 
Sathuvam   -                      Rasatham -                         Thamasam  - 
 
9.IMPORIGAL (SENSORY ORGANS)  
Mei 
Vai 
Kan 
Mooku 
Sevi 
10. KANMENDRIYAM ( MOTOR ORGANS) 
Kai 
Kaal 
Vaai 
Eruvai 
Karuvai 
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11.KOSANGAL(Sheath)   
 0
th 
Day 48
th 
Day
 
AnnamayaKosam   
Pranamayakosam   
Manomayakosam   
Vignanamayakosam   
Ananthamayakosam   
 
12. MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
A)VATHAM: 
 Praanan 
 Abaanan 
 Viyaanan 
 Udhaanan 
 Samanan 
 Naagan 
 Koorman 
 Kirugaran 
 Dhevathathan 
 Dhananjeyan 
 
B) PITHAM: 
 Analpitham 
 Ranjagam 
      Sathagam 
      Prasagam 
      Aalosagam                                            
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C) KABHAM: 
 Avalambagam 
      Kilethagam 
      Pothagam 
      Tharpagam 
      Santhigam 
13.UDAL THATHUKAL[SEVEN DHATHUS]:    
 Saaram 
 Seneer 
 Oon 
 Koluppu 
 Enbu 
 Moolai 
 Sukilam/Suronitham     
14.GENERAL EXAMINATION 
Consciousness : 
Position : 
Attitude : 
Pulse Rate : 
Heart Rate : 
Temperature : 
Respiratory Rate : 
Blood Pressure : 
Anaemia : 
Jaundice : 
Cyanosis : 
Clubbing : 
Oedema : 
Significant Lymph adenopathy : 
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15.SYSTEMIC EXAMINATION: 
Central Nervous System 
Cardio vascular system 
Respiratory system 
Gastro intestinal system 
Genito urinary system 
 
OVERALL ASSESSMENT CRITERIA OF THE STUDY  
S.NO SIGNS AND 
SYMPTOMS 
BEORE 
TREATMENT 
ATER 
TREATMENT 
1 PAIN   
2 SWELLING   
3 REDNESS   
4 TENDERNESS   
5 JOINT STINESS   
6 JOINT DEORMITY   
7 LOSS O JOINT RANGE 
OF MOTION 
  
 
 
Signature of the Investigator : Signature of the Guide / HOD  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO  EVALUATE 
THE THERAPEUTIC EFFICACYOF KODIVELI CHOORANAM [INTERNAL] 
AND  THIRUGUKALLI YENNAI [EXTERNAL] WITH OTRADAM  
[EXTERNAL THERAPY] IN SANTHU VATHAM [POLYARTHRITIES]. 
FORM  V 
LABORATORY INVESTIGATION FORM 
 
S.NO :                                       OP/IP NO: 
NAME:                                       AGE:                                      SEX: 
I.BLOOD 
  Before Treatment After Treatment 
1 
 
TC (cells/mm)   
2 DC  
 
 
3 
 
ESR(mm) 
 
 
 
 
4 
 
Hemoglobin   
5 
 
Blood glucose   
6 
 
Blood urea / creatinine   
7 Serum cholesterol  
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II. URINE 
  
 
Before Treatment After Treatment 
1 
 
Albumin 
 
  
2 Sugar 
 
  
3 Deposit 
 
  
 
SPECIAL INVESTIGATION: 
RA  FACTOR   : 
CRP                   : 
 
Date  :       
Station : 
Signature of the Investigator : 
 
                               Signature of the Guide /HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO  EVALUATE 
THE THERAPEUTIC EFFICACY OF KODIVELI CHOORANAM [INTERNAL] 
AND  THIRUGUKALLI YENNAI [EXTERNAL] WITH OTRADAM 
[EXTERNAL THERAPY] IN SANTHU VATHAM [POLYARTHRITIES]. 
FORM VI 
(DRUG COMPLIANCE FORM) 
OPD/ IPD No : ____________ DOA      : ________________       
 Name : _____________________ Age/ Sex : ___________     S. No : _________ 
Name Of The Drug :  KODIVELI CHOORANAM 
 
S.NO DATE MORNING SIGN 
1.     
2.     
3.     
4.     
5.     
6.     
7.     
8.     
9.     
10.     
11.     
12.     
13.     
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14.     
15.     
16.     
17.     
18.     
19.     
20.     
21.     
22.     
23.     
24.     
25.     
26.     
27.     
28.     
29.     
30.     
31.     
32.     
33.     
34.     
35.     
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36.     
37.     
38.     
39.     
40.     
41.     
42.     
43.     
44.     
45.     
46.     
47.     
48.     
 
DATE: 
         
SIGNATURE OF THE INVESTIGATOR       SIGNATURE OF THE GUIDE/HOD                                                                                                                                          
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO  EVALUATE 
THE THERAPEUTIC EFFICACY  OF KODIVELI CHOORANAM [INTERNAL] 
AND  THIRUGUKALLI YENNAI [EXTERNAL] WITH OTRADAM  
[EXTERNAL THERAPY] IN SANTHU VATHAM [POLYARTHRITIES]. 
FORM  VII 
ADVERSE DRUG REACTION FORM 
Name: ________________________       OPD/ IPD No : __________ 
Age: ________            Gender: ________        
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: 
_______________________________________________ 
________________________________________________________________________ 
 
Date: 
Station:  
       
SIGNATURE  OF  INVESTIGATOR         SIGNATURE  OF   THE GUIDE / HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO  EVALUATE 
THE THERAPEUTIC EFFICACYOF KODIVELI CHOORANAM [INTERNAL] 
AND  THIRUGU KALLI YENNAI [EXTERNAL] WITH OTRADAM  
[EXTERNAL THERAPY] IN SANTHU VATHAM [POLYARTHRITIES]. 
FORM VIII 
WITHDRAWAL FORM 
Name: ________________________       OPD/ IPD number: __________ 
Age   : ________              Gender   : ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal: 
            YES     NO  
 Long absence in without reporting   
 Irregular treatment     
 Shift of locality                                                 
 Increase in severity of symptoms  
 Development of severe adverse drug reactions   
Date    :      
Station :     
 
 
SIGNATURE  OF  INVESTIGATOR        SIGNATURE  OFGUIDE / HOD 
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